FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Harvey White

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Cheuk-Kit Wong; Harvey D White
Rivaroxaban for the treatment of acute coronary syndromes.
Deepak L Bhatt; Ezio Bramucci; Dianne Gallup; Philippe Généreux; C Michael Gibson; Christian W Hamm; Robert A Harrington; Sergio Leonardi; Tiepu Liu; Kenneth W Mahaffey; Brent T McLaurin; Jayne Prats; Matthew J Price; Peter W Radke; Simona Skerjanec; Douglas Spriggs; P Gabriel Steg; Gregg W Stone; Jeffrey Tauth; Meredith Todd; Frantisek Tousek; Harvey D White; Petr Widimský; Dominick J Angiolillo
Effect of platelet inhibition with cangrelor during PCI on ischemic events.
Jason J Rose; Frans Van de Werf; Harvey D White; Kenneth W Mahaffey; L Kristin Newby; E Magnus Ohman; Paul W Armstrong; Samuel Broderick; Robert M Califf; Karen Chiswell; Robert P Giugliano; Shaun G Goodman; Christopher B Granger; Robert A Harrington; Renato D Lopes
Left bundle branch block in non-ST-segment elevation acute coronary syndromes. Incidence, angiographic characteristics, and clinical outcomes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Harvey White (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Cheuk-Kit Wong; Harvey D White
Rivaroxaban for the treatment of acute coronary syndromes.
Expert opinion on pharmacotherapy 2013;14(7):917-27.
2013: Deepak L Bhatt; Ezio Bramucci; Dianne Gallup; Philippe Généreux; C Michael Gibson; Christian W Hamm; Robert A Harrington; Sergio Leonardi; Tiepu Liu; Kenneth W Mahaffey; Brent T McLaurin; Jayne Prats; Matthew J Price; Peter W Radke; Simona Skerjanec; Douglas Spriggs; P Gabriel Steg; Gregg W Stone; Jeffrey Tauth; Meredith Todd; Frantisek Tousek; Harvey D White; Petr Widimský; Dominick J Angiolillo
Effect of platelet inhibition with cangrelor during PCI on ischemic events.
The New England journal of medicine 2013;368(14):1303-13.
2013: Jason J Rose; Frans Van de Werf; Harvey D White; Kenneth W Mahaffey; L Kristin Newby; E Magnus Ohman; Paul W Armstrong; Samuel Broderick; Robert M Califf; Karen Chiswell; Robert P Giugliano; Shaun G Goodman; Christopher B Granger; Robert A Harrington; Renato D Lopes
Left bundle branch block in non-ST-segment elevation acute coronary syndromes. Incidence, angiographic characteristics, and clinical outcomes.
Journal of the American College of Cardiology 2013;61(13):1461-3.
2012: Sergio Leonardi; Renato D Lopes; Elliott M Antman; Paul W Armstrong; Robert M Califf; Robert P Giugliano; Megan L Neely; L Kristin Newby; Laine Thomas; Pierluigi Tricoci; Harvey D White; Kenneth W Mahaffey
Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction.
Journal of the American College of Cardiology 2012;60(22):2296-304.
2012: Timothy A C Snow; Sally C Greaves; Julian P McEntee; Harvey D White
Myocardial infarction following sclerotherapy in a patient with a patent foramen ovale.
The New Zealand medical journal 2012;125(1366):64-7.
2012: Paul A Gurbel; Kurt Huber; Joseph A Jakubowski; Benjamin Neely; Megan Neely; E Magnus Ohman; Dorairaj Prabhakaran; Matthew T Roe; Udaya S Tantry; Harvey D White; Chunmei Zhou; Paul W Armstrong; Eileen Brown; Mark Y Chan; Jan H Cornel; David Erlinge; Keith A A Fox; Shaun G Goodman
Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy.
JAMA : the journal of the American Medical Association 2012;308(17):1785-94.
2012: G Dangas; Martin Fahy; José P S Henriques; Roxana Mehran; E Magnus Ohman; Helen Parise; Harvey D White; Ke Xu; Bimmer E Claessen; Gregg W Stone
Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes.
JACC. Cardiovascular interventions 2012;5(11):1097-105.
2012: Kristian Thygesen; Harvey D White; Joseph S Alpert; Bernard R Chaitman; Allan S Jaffe; Maarten L Simoons
Third universal definition of myocardial infarction.
Nature reviews. Cardiology 2012;9(11):620-33.
2012: Kristian Thygesen; Harvey D White; Carlos Aguiar; Wael Almahmeed; Joseph S Alpert; Elliott M Antman; Fred S Apple; Paul W Armstrong; David O Arnar; Dan Atar; Fabio Barili; Jean-Pierre Bassand; Helmut Baumgartner; Jeroen J Bax; Jeroen J Bax; Kenneth D Bloch; Ann F Bolger; Jeroen J Bonow; Hans Erik Botker; Alfred A Bove; Biykem Bozkurt; Raffaele Bugiardini; Christopher Cannon; Claudio Ceconi; Bernard R Chaitman; Peter M Clemmensen; James de Lemos; Veronica Dean; Christi Deaton; Franz R Eberli; Edgardo Escobar; Robert Fagard; Gerasimos Filippatos; Stephen P Fortmann; Keith A Fox; Christian Funck-Brentano; Marcello Galvani; Mihai Gheorghiade; Raymond J Gibbons; Christian W Hamm; David Hasdai; Mark Hlatky; Hanoch Hod; Arno Hoes; Dayi Hu; Allan S Jaffe; Stefan James; James L Januzzi; Per Johanson; Hugo A Katus; Karl B Kern; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Dan Levy; Bertil Lindahl; Jose-Luis Lopez-Sendon; Russell V Luepker; Theresa McDonagh; Phillippe Menasche; Shanti Mendis; David J Moliterno; Joao Morais; David A Morrow; Cyril Moulin; Christian Mueller; Aleksandar N Neskovic; L Kristin Newby; Markku S Nieminen; E Magnus Ohman; Alexander N Parkhomenko; Burkert Mathias Pieske; Fausto Pinto; Bogdan A Popescu; Jan Ravkilde; Zeljko Reiner; Rose Marie Robertson; Wayne D Rosamond; Steven P Schulman; Udo Sechtem; Maarten L Simoons; Per Anton Sirnes; Sidney C Smith; Ph Gabriel Steg; Robert F Storey; Kathryn A Taubert; Michal Tendera; Michal Tendera; Kristian Thygesen; Adam Torbicki; Richard Underwood; Barry F Uretsky; Alec Vahanian; Elena J Vasilieva; Pascal Vranckx; Joseph S Alpert; Bernard R Chaitman; Allan S Jaffe; Maarten L Simoons; Lars C Wallentin; Douglas Weaver; Harvey D White; William Wijns; Stephan Windecker; David Wood; Daniel R Wagner
Third universal definition of myocardial infarction.
Journal of the American College of Cardiology 2012;60(16):1581-98.
2012: Kristian Thygesen; Harvey D White; Joseph S Alpert; Bernard R Chaitman; Allan S Jaffe; Maarten L Simoons
Third universal definition of myocardial infarction.
European heart journal 2012;33(20):2551-67.
2012: Cheuk-Kit Wong; Harvey D White
Patients with circumflex occlusions miss out on reperfusion: how to recognize and manage them.
Current opinion in cardiology 2012;27(4):327-30.
2012: Sergio Leonardi; Tiepu Liu; Kenneth W Mahaffey; Matthew J Price; Simona Skerjanec; Gabriel W Steg; Gregg W Stone; Meredith Todd; Harvey D White; Markus Dietrich; Dianne Gallup; C Michael Gibson; Christian W Hamm; Robert A Harrington; Deepak L Bhatt
Rationale and design of the Cangrelor versus standard therapy to acHieve optimal Management of Platelet InhibitiON PHOENIX trial.
American heart journal 2012;163(5):768-776.e2.
2012: Harvey D White; Warren Cantor; Antonio C Carvalho; Vladimír Džavík; Genell L Knatterud; Mariusz Kruk; Gervasio A Lamas; Li Liu; C Edwin Martin; Venu Menon; Camille A Pearte; Harmony R Reynolds; Philippe Gabriel STEG; Judith S Hochman
Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: results from long-term follow-up of the Occluded Artery Trial (OAT) cohort.
American heart journal 2012;163(4):563-71.
2012: Harvey D White
The prequel: defining prognostically important criteria in the periprocedural PCI troponin saga.
Circulation. Cardiovascular interventions 2012;5(2):142-5.
2012: Roxana Mehran; Philippe Gabriel STEG; Harvey D White; Sunil V Rao
Letter by Mehran et al regarding article, "Bleeding academic research consortium consensus report: the food and drug administration perspective".
Circulation 2012;125(10):e460.
2012: Adam Skolnick; Harvey D White; Rudyney E U Azevedo; Antonio C Carvalho; Sandra A Forman; Luis Gruberg; Judith S Hochman; Gervasio A Lamas; Aldo P Maggioni; Venu Menon; Camille A Pearte; Harmony R Reynolds; Erwin Schroeder; Vladimír Džavík
Comparison of late results of percutaneous coronary intervention among stable patients ≤65 versus >65 years of age with an occluded infarct related artery (from the Occluded Artery Trial).
The American journal of cardiology 2012;109(5):614-9.
2012: Harvey D White; Derek P Chew; Harold L Dauerman; C Michael Gibson; Luis Gruberg; Robert A Harrington; Kenneth W Mahaffey; Gregg W Stone; Deepak L Bhatt
Reduced immediate ischemic events with cangrelor in PCI: a pooled analysis of the CHAMPION trials using the universal definition of myocardial infarction.
American heart journal 2012;163(2):182-90.e4.
2012: Rajendra H Mehta; Karen S Pieper; Amanda S Stebbins; Eric J Topol; Frans Van de Werf; Harvey D White; John H Alexander; Paul W Armstrong; Robert M Califf; Judith S Hochman; Renato D Lopes; Christopher B Granger
Comparison of incidence of bleeding and mortality of men versus women with ST-elevation myocardial infarction treated with fibrinolysis.
The American journal of cardiology 2012;109(3):320-6.
2012: Cheuk-Kit Wong; Philip E G Aylward; John K French; Wanzhen Gao; Ralph A H Stewart; Harvey D White
The prognostic meaning of the full spectrum of aVR ST-segment changes in acute myocardial infarction.
European heart journal 2012;33(3):384-92.
2012: Ralph A H Stewart; Heather Astell; Laura Young; Harvey D White
Thrombosis on a Mechanical Aortic Valve whilst Anti-coagulated With Dabigatran.
Heart, lung & circulation 2012;21(1):53-5.
2011: Cheuk-Kit Wong; Harvey D White
Effects of dietary factors on lipoprotein-associated phospholipase A(2) (Lp-PLA (2)).
Current atherosclerosis reports 2011;13(6):461-6.
2011: Michelle L O'Donoghue; Patrick Serruys; Ph Gabriel Steg; Elizabeth Tarka; Douglas Weaver; Harvey D White; Greg Cicconetti; Judith Hochman; Joel L Johnson; Mary Ann Lukas; Aldo P Maggioni; Christoph Bode; Eugene Braunwald; Christopher P Cannon
Study design and rationale for the Stabilization of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome.
American heart journal 2011;162(4):613-619.e1.
2011: Andrew Old; Brandon Adams; Peter Foley; Harvey D White
Society's expectation of the role of the doctor in New Zealand: results of a national survey.
The New Zealand medical journal 2011;124(1342):10-22.
2011: Derek P Chew; Anne-Maree Kelly; Constantine N Aroney; Philip E Aylward; Leva Azadi; Philip A Tideman; Jill Waddell; Harvey D White; Alison J Wilson; Leah-Anne M Ruta
2011 Addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines for the management of acute coronary syndromes (ACS) 2006.
Heart, lung & circulation 2011;20(8):487-502.
2011: Renato D Lopes; Kenneth W Mahaffey; Helena B Nader; L Kristin Newby; Eric D Peterson; Karen S Pieper; Frans Van de Werf; Lars Wallentin; Harvey D White; John H Alexander; Paul W Armstrong; Richard C Becker; Joyce M A Bizzachi; Robert M Califf; Antonio C Carvalho; Mark Y Chan; Mark Crowther; Roberto R Giraldez; Christopher B Granger; Helio P Guimaraes; Robert A Harrington; Elaine M Hylek; Stefan K James; E Marc Jolicoeur; Renato A K Kalil; Antonio C Lopes; David A Garcia
Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, Brazil.
Journal of thrombosis and thrombolysis 2011;32(2):242-66.
2011: Jocelyne R Benatar; Patrick Gladding; Harvey D White; Irene Zeng; Ralph A H Stewart
Trans-fatty acids in New Zealand patients with coronary artery disease.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2011;18(4):615-20.
2011: Kenji Goto; Martial Hamon; Alexandra J Lansky; Roxana Mehran; Eugenia Nikolsky; E Magnus Ohman; Michel E Bertrand; Walter Desmet; Martin Fahy; Frederick Feit; Harvey D White; Gregg W Stone
Prognostic significance of coronary thrombus in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a subanalysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
JACC. Cardiovascular interventions 2011;4(7):769-77.
2011: Pierluigi Tricoci; Frans Van de Werf; Harvey D White; Paul W Armstrong; Leonardo Bolognese; Eugene Braunwald; Robert M Califf; Eric Durand; Robert P Giugliano; Vic Hasselblad; David F Kong; David J Moliterno; L Kristin Newby; Dorairaj Prabhakaran; Saman Rasoul; Gregg W Stone; Pierre Théroux; Robert A Harrington
Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic overview of randomized clinical trials.
Circulation. Cardiovascular quality and outcomes 2011;4(4):448-58.
2011: Harvey D White
Editorial: do we need another bleeding definition? What does the Bleeding Academic Research Consortium definition have to offer?
Current opinion in cardiology 2011;26(4):275-8.
2011: Gilles Montalescot; Genevieve Salette; Gabriel Steg; Marc Cohen; Richard Gallo; Harvey D White; Steven R Steinhubl
Development and validation of a bleeding risk model for patients undergoing elective percutaneous coronary intervention.
International journal of cardiology 2011;150(1):79-83.
2011: Harvey D White
Response to 'lifetime cardiovascular risk' letter.
The New Zealand medical journal 2011;124(1337):119-20.
2011: Harvey D White
Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis?
Journal of the American College of Cardiology 2011;57(24):2406-8.
2011: Harvey D White
Improving cardiovascular risk assessment.
The New Zealand medical journal 2011;124(1335):5-9.
2011: Alexandra Lansky; Roxana Mehran; E Magnus Ohman; Gregg W Stone; Harvey D White; Karen P Alexander; Michel E Bertrand; Ecatarina Cristea; Walter Desmet; Martin Fahy; Frederick Feit; Kenji Goto; Martial Hamon
Response to letters regarding article, “Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) substudy”.
Circulation 2011;123(15):e410-1.
2011: Ralph A H Stewart; Harvey D White
The role of lipoprotein-associated phospholipase a₂ as a marker and potential therapeutic target in atherosclerosis.
Current atherosclerosis reports 2011;13(2):132-7.
2011: Harvey D White
Oral antiplatelet therapy for atherothrombotic disease: current evidence and new directions.
American heart journal 2011;161(3):450-61.
2011: Kenneth W Mahaffey; Karen S Pieper; Yuliya Lokhnygina; Robert M Califf; Elliott M Antman; Neal S Kleiman; Shaun G Goodman; Harvey D White; Sunil V Rao; Judith S Hochman; Marc Cohen; Jacques J Col; Matthew T Roe; James J Ferguson
The impact of postrandomization crossover of therapy in acute coronary syndromes care.
Circulation. Cardiovascular quality and outcomes 2011;4(2):211-9.
2011: Diaa A Hakim; George Dangas; Adriano Caixeta; Eugenia Nikolsky; Alexandra J Lansky; Jeffrey W Moses; Bimmer Claessen; Elias Sanidas; Harvey D White; E Magnus Ohman; Steven V Manoukian; Martin Fahy; Roxana Mehran; Gregg W Stone
Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial.
American heart journal 2011;161(2):391-6.
2011: Adriano Caixeta; George Dangas; Roxana Mehran; Frederick Feit; Eugenia Nikolsky; Alexandra J Lansky; Jiro Aoki; Jeffrey W Moses; Steven R Steinhubl; Harvey D White; E Magnus Ohman; Steven V Manoukian; Martin Fahy; Gregg W Stone
Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial.
American heart journal 2011;161(2):298-306.e1.
2011: Cheuk-Kit Wong; Harvey D White
Antithrombotic therapy in ST-segment elevation myocardial infarction.
Expert opinion on pharmacotherapy 2011;12(2):213-23.
2011: Adriano Caixeta; Gregg W Stone; Roxana Mehran; Edwin A Lee; Brent T McLaurin; David A Cox; Michel E Bertrand; A Michael Lincoff; Jeffrey W Moses; Harvey D White; E Magnus Ohman; Tullio Palmerini; George Syros; Christos Kittas; Martin Fahy; W Craig Hooper; Alexandra J Lansky; George D Dangas
Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trial.
Journal of thrombosis and thrombolysis 2011;31(2):154-64.
2011: Giuseppe Ambrosio; Steven Steinhubl; Paolo Gresele; Isabella Tritto; Cinzia Zuchi; Michel E Bertrand; A Michael Lincoff; Jeffrey W Moses; Erik M Ohman; Harvey D White; Roxana Mehran; Gregg W Stone
Impact of chronic antiplatelet therapy before hospitalization on ischemic and bleeding events in invasively managed patients with acute coronary syndromes: the ACUITY trial.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2011;18(1):121-8.
2011: Rajendra H Mehta; J Conor O'Shea; Amanda L Stebbins; Christopher B Granger; Paul W Armstrong; Harvey D White; Eric J Topol; Robert M Califf; E Magnus Ohman
Association of mortality with years of education in patients with ST-segment elevation myocardial infarction treated with fibrinolysis.
Journal of the American College of Cardiology 2011;57(2):138-46.
2011: Rajendra H Mehta; Amanda Stebbins; Renato D Lopes; Sunil V Rao; Eric R Bates; Karen S Pieper; Paul W Armstrong; Frans Van de Werf; Harvey D White; Robert M Califf; John H Alexander; Christopher B Granger
Race, Bleeding, and Outcomes in STEMI Patients Treated with Fibrinolytic Therapy.
The American journal of medicine 2011;124(1):48-57.
2011: Jonathan P Piccini; Phillip J Schulte; Karen S Pieper; Rajendra H Mehta; Harvey D White; Frans Van de Werf; Diego Ardissino; Robert M Califf; Christopher B Granger; E Magnus Ohman; John H Alexander
Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction.
Critical care medicine 2011;39(1):78-83.
2010: Harvey D White
The ATOLL trial of enoxaparin in primary percutaneous coronary intervention.
European heart journal 2010;31(23):2826-7.
2010: Shamir R Mehta; Jean-Francois Tanguay; John W Eikelboom; Sanjit S Jolly; Campbell D Joyner; Christopher B Granger; David P Faxon; Hans-Jurgen Rupprecht; Andrzej Budaj; Alvaro Avezum; Petr Widimsky; Philippe Gabriel STEG; Jean-Pierre Bassand; Gilles Montalescot; Carlos Macaya; Giuseppe Di Pasquale; Kari Niemela; Andrew E Ajani; Harvey D White; Susan Chrolavicius; Peggy Gao; Keith A A Fox; Salim Yusuf
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial.
Lancet 2010;376(9748):1233-43.
2010: Amanda L Stebbins; Rajendra H Mehta; Paul W Armstrong; Kerry L Lee; Christian Hamm; Frans Van de Werf; Stefan James; Torsten Toftegaard-Nielsen; Ricardo Seabra-Gomes; Harvey D White; Christopher B Granger
A model for predicting mortality in acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: results from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial.
Circulation. Cardiovascular interventions 2010;3(5):414-22.
2010: Sarah A Spinler; Kenneth W Mahaffey; Dianne Gallup; Glenn N Levine; James J Ferguson; Sunil V Rao; Richard Gallo; John Ducas; Shaun G Goodman; Elliott Antman; Harvey D White; Luigi Biasucci; Richard C Becker; Jacques J Col; Marc Cohen; Robert A Harrington; Robert M Califf
Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: results from SYNERGY.
International journal of cardiology 2010;144(1):36-41.
2010: Paul Schoenhagen; Harvey D White
Magnetic resonance imaging and troponin elevation following percutaneous coronary intervention: new insights into myocyte necrosis and scar formation.
JACC. Cardiovascular interventions 2010;3(9):959-62.
2010: Lynn A Sleeper; Harmony R Reynolds; Harvey D White; John G Webb; Vladimir Dzavík; Judith S Hochman
A severity scoring system for risk assessment of patients with cardiogenic shock: a report from the SHOCK Trial and Registry.
American heart journal 2010;160(3):443-50.
2010: Ralph A H Stewart; Andrew J Kerr; Gillian Whalley; Malcolm E Legget; Irene Zeng; Michael J A Williams; John Lainchbury; Andrew Hamer; Robert N Doughty; Mark A Richards; Harvey D White
Left ventricular systolic and diastolic function assessed by tissue Doppler imaging and outcome in asymptomatic aortic stenosis.
European heart journal 2010;31(18):2216-22.
2010: David A Morrow; Elliott M Antman; Keith A A Fox; Harvey D White; Robert P Giugliano; Sabina A Murphy; Carolyn H McCabe; Eugene Braunwald
One-year outcomes after a strategy using enoxaparin vs. unfractionated heparin in patients undergoing fibrinolysis for ST-segment elevation myocardial infarction: 1-year results of the ExTRACT-TIMI 25 trial.
European heart journal 2010;31(17):2097-102.
2010: Cheuk-Kit Wong; Wanzhen Gao; Ralph A Stewart; John K French; Philip E Aylward; Jocelyne Benatar; Harvey D White
Prognostic value of lead V1 ST elevation during acute inferior myocardial infarction.
Circulation 2010;122(5):463-9.
2010: Alexandra J Lansky; Kenji Goto; Ecaterina Cristea; Martin Fahy; Helen Parise; Frederick Feit; E Magnus Ohman; Harvey D White; Karen P Alexander; Michel E Bertrand; Walter Desmet; Martial Hamon; Roxana Mehran; Jeffrey Moses; Martin Leon; Gregg W Stone
Clinical and angiographic predictors of short- and long-term ischemic events in acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial.
Circulation. Cardiovascular interventions 2010;3(4):308-16.
2010: Cheuk-Kit Wong; Wanzhen Gao; Ralph A H Stewart; Jocelyne Benatar; John K French; Philip E G Aylward; Harvey D White
aVR ST elevation: an important but neglected sign in ST elevation acute myocardial infarction.
European heart journal 2010;31(15):1845-53.
2010: Ajay J Kirtane; Helen Parise; Roxana Mehran; Jeffrey W Moses; Martin Fahy; Michel E Bertrand; E Magnus Ohman; Harvey D White; Frederick Feit; Antonio Colombo; Brent T McLaurin; David A Cox; James H Ware; Stuart J Pocock; Alexandra J Lansky; Gregg W Stone
Comparison of catheterization laboratory initiated abciximab and eptifibatide during percutaneous coronary intervention in acute coronary syndromes (an ACUITY substudy).
The American journal of cardiology 2010;106(2):180-6.
2010: Chee Tang Chin; Matthew T Roe; Keith A A Fox; Dorairaj Prabhakaran; Debra A Marshall; Helene Petitjean; Yuliya Lokhnygina; Eileen Brown; Paul W Armstrong; Harvey D White; E Magnus Ohman
Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.
American heart journal 2010;160(1):16-22.e1.
2010: Ph Gabriel Steg; Arthur Kerner; G B John Mancini; Harmony R Reynolds; Antonio C Carvalho; Viliam Fridrich; Harvey D White; Sandra A Forman; Gervasio A Lamas; Judith S Hochman; Christopher E Buller
Impact of collateral flow to the occluded infarct-related artery on clinical outcomes in patients with recent myocardial infarction: a report from the randomized occluded artery trial.
Circulation 2010;121(25):2724-30.
2010: R John Simes; Rachel L O'Connell; Philip E Aylward; Sergei Varshavsky; Rafael Diaz; Robert G Wilcox; Paul W Armstrong; Christopher B Granger; John K French; Frans Van de Werf; Ian C Marschner; Rob Califf; Harvey D White
Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial.
American heart journal 2010;159(6):988-97.
2010: Harvey D White
Higher sensitivity troponin levels in the community: what do they mean and how will the diagnosis of myocardial infarction be made?
American heart journal 2010;159(6):933-6.
2010: Kent R Nilsson; Sana M Al-Khatib; Yi Zhou; Karen Pieper; Harvey D White; Aldo P Maggioni; Lars Kober; Christopher B Granger; Eldrin F Lewis; John J V McMurray; Robert M Califf; Eric J Velazquez
Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial.
Heart (British Cardiac Society) 2010;96(11):838-42.
2010: E Magnus Ohman; Matthew T Roe; Paul W Armstrong; Keith A Fox; Dorairaj Prabhakaran; Harvey D White
Public sensationalism and clinical trials: how to address the challenges of science?
The American journal of medicine 2010;123(6):481-3.
2010: Marc Cohen; Glenn N Levine; Karen S Pieper; Lan Lan; Elliott M Antman; Philip E Aylward; Harvey D White; Neal S Kleiman; Robert M Califf; Kenneth W Mahaffey
Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2010;75(6):928-35.
2010: Robert M Califf; Paul W Armstrong; Christopher B Granger; Robert A Harrington; Kerry Lee; R John Simes; Frans Van de Werf; Lars Wallentin; Harvey D White
Towards a new order in cardiovascular medicine: re-engineering through global collaboration.
European heart journal 2010;31(8):911-7.
2010: Raymond T Yan; Andrew T Yan; Kenneth W Mahaffey; Harvey D White; Karen Pieper; Jie Lena Sun; Carl J Pepine; Luigi M Biasucci; Dietrich C Gulba; Jose Lopez-Sendon; Shaun G Goodman
Prognostic utility of quantifying evolutionary ST-segment depression on early follow-up electrocardiogram in patients with non-ST-segment elevation acute coronary syndromes.
European heart journal 2010;31(8):958-66.
2010: Kenneth W Mahaffey; Simon T Tonev; Sarah A Spinler; Glenn N Levine; Richard Gallo; John Ducas; Shaun G Goodman; Elliott M Antman; Richard C Becker; Anatoly Langer; Harvey D White; Philip E Aylward; Jacques J Col; James J Ferguson; Robert M Califf
Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
International journal of cardiology 2010;139(2):123-33.
2010: Michael C Tjandrawidjaja; Yuling Fu; Cynthia M Westerhout; Harvey D White; Thomas G Todaro; Frans Van de Werf; Kenneth W Mahaffey; Galen S Wagner; Christopher B Granger; Paul W Armstrong
Resolution of ST-segment depression: A new prognostic marker in ST-segment elevation myocardial infarction.
European heart journal 2010;31(5):573-81.
2010: Kenji Goto; Alexandra J Lansky; Martin Fahy; Ecatarina Cristea; Frederick Feit; Erik Ohman; Harvey D White; Karen P Alexander; Michel E Bertrand; Walter Desmet; Martial Hamon; Roxana Mehran; Gregg W Stone
Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization And Urgent Intervention Triage Strategy (ACUITY) substudy.
Circulation 2010;121(7):853-62.
2010: Harvey D White
Systems of care: need for hub and spoke systems of care for patients with myocardial infarction. A call for action.
The New Zealand medical journal 2010;123(1309):7-10.
2010: Renato D Lopes; Aijing Starr; Carl F Pieper; Sana M Al-Khatib; L Kristin Newby; Rajendra H Mehta; Frans Van de Werf; Kenneth W Mahaffey; Paul W Armstrong; Robert A Harrington; Harvey D White; Lars Wallentin; Christopher B Granger
Warfarin use and outcomes in patients with atrial fibrillation complicating acute coronary syndromes.
The American journal of medicine 2010;123(2):134-40.
2010: Vinod Jorapur; Gervasio A Lamas; Zygmunt P Sadowski; Harmony R Reynolds; Antonio C Carvalho; Christopher E Buller; James M Rankin; Jean Renkin; Philippe Gabriel STEG; Harvey D White; Carlos Vozzi; Eduardo Balcells; Michael Ragosta; C Edwin Martin; Vankeepuram Srinivas; William W Wharton Iii; Staci Abramsky; Ana C Mon; Shari S Kronsberg; Judith S Hochman
Renal impairment and heart failure with preserved ejection fraction early post-myocardial infarction.
World journal of cardiology 2010;2(1):13-8.
2010: Stuart J Pocock; Roxana Mehran; Tim C Clayton; Eugenia Nikolsky; Helen Parise; Martin Fahy; Alexandra J Lansky; Michel E Bertrand; A Michael Lincoff; Jeffrey W Moses; Erik Ohman; Harvey D White; Gregg W Stone
Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trial.
Circulation 2010;121(1):43-51.
2010: Harvey D White; Philip E G Aylward; Richard Gallo; Christoph Bode; Gabriel Steg; Steven R Steinhubl; Gilles Montalescot
Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial.
American heart journal 2010;159(1):110-6.
2009: Deepak L Bhatt; A Michael Lincoff; C Michael Gibson; Gregg W Stone; Steven McNulty; Gilles Montalescot; Neal S Kleiman; Shaun G Goodman; Harvey D White; Kenneth W Mahaffey; Charles V Pollack; Steven V Manoukian; Petr Widimsky; Derek P Chew; Fernando Cura; Ivan Manukov; Frantisek Tousek; M Zubair Jafar; Jaspal Arneja; Simona Skerjanec; Robert A Harrington
Intravenous platelet blockade with cangrelor during PCI.
The New England journal of medicine 2009;361(24):2330-41.
2009: Robert A Harrington; Gregg W Stone; Steven McNulty; Harvey D White; A Michael Lincoff; C Michael Gibson; Charles V Pollack; Gilles Montalescot; Kenneth W Mahaffey; Neal S Kleiman; Shaun G Goodman; Maged Amine; Dominick J Angiolillo; Richard C Becker; Derek P Chew; William J French; Franz Leisch; Keyur H Parikh; Simona Skerjanec; Deepak L Bhatt
Platelet inhibition with cangrelor in patients undergoing PCI.
The New England journal of medicine 2009;361(24):2318-29.
2009: Gilles Montalescot; Richard Gallo; Harvey D White; Marc Cohen; Ph Gabriel Steg; Philip E G Aylward; Christoph Bode; Massimo Chiariello; Spencer B King; Robert A Harrington; Walter Desmet; Carlos Macaya; Steven R Steinhubl
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trial.
JACC. Cardiovascular interventions 2009;2(11):1083-91.
2009: Harvey D White
Is there an acceptable ceiling for bleeding for an antithrombotic drug dose to be tested in a phase 3 trial?
European heart journal 2009;30(21):2556-7.
2009: Eugenia Nikolsky; Gregg W Stone; Ajay J Kirtane; George Dangas; Alexandra J Lansky; Brent McLaurin; A Michael Lincoff; Frederick Feit; Jeffrey W Moses; Martin Fahy; Steven V Manoukian; Harvey D White; Erik Ohman; Michel E Bertrand; David A Cox; Roxana Mehran
Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
Journal of the American College of Cardiology 2009;54(14):1293-302.
2009: George V Moukarbel; James E Signorovitch; Marc A Pfeffer; John J V McMurray; Harvey D White; Aldo P Maggioni; Eric J Velazquez; Robert M Califf; James M Scheiman; Scott D Solomon
Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial.
European heart journal 2009;30(18):2226-32.
2009: Jeffrey S Berger; Laine Elliott; Dianne Gallup; Matthew Roe; Christopher B Granger; Paul W Armstrong; R John Simes; Harvey D White; Frans Van de Werf; Eric J Topol; Judith S Hochman; L Kristin Newby; Robert A Harrington; Robert M Califf; Richard C Becker; Pamela S Douglas
Sex differences in mortality following acute coronary syndromes.
JAMA : the journal of the American Medical Association 2009;302(8):874-82.
2009: Roxana Mehran; Eugenia Nikolsky; Alexandra J Lansky; Ajay J Kirtane; Young-Hak Kim; Frederick Feit; Steven V Manoukian; Jeffrey W Moses; Ramin Ebrahimi; Erik Ohman; Harvey D White; Stuart J Pocock; George Dangas; Gregg W Stone
Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) substudy.
JACC. Cardiovascular interventions 2009;2(8):748-57.
2009: Renato D Lopes; Laine E Elliott; Harvey D White; Judith S Hochman; Frans Van de Werf; Diego Ardissino; Torsten T Nielsen; W Douglas Weaver; Petr Widimsky; Paul W Armstrong; Christopher B Granger
Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial.
European heart journal 2009;30(16):2019-28.
2009: Abhiram Prasad; Bernard J Gersh; Michel E Bertrand; A Michael Lincoff; Jeffrey W Moses; Erik Ohman; Harvey D White; Stuart J Pocock; Brent T McLaurin; David A Cox; Alexandra J Lansky; Roxana Mehran; Gregg W Stone
Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
Journal of the American College of Cardiology 2009;54(5):477-86.
2009: John K French; Shannon Harkness; Lynn Sleeper; S Chiu Wong; Jacques Col; Vladimir Dzavik; Harvey D White; Judith S Hochman
Cardiogenic shock without flow-limiting angiographic coronary artery disease: (from the Should We Emergently Revascularize Occluded Coronary Arteries for Cardiogenic Shock Trial and Registry).
The American journal of cardiology 2009;104(1):24-8.
2009: Harvey D White
Strategies to minimize bleeding complications of percutaneous coronary intervention.
Current opinion in cardiology 2009;24(4):273-8.
2009: David A Morrow; Stephen D Wiviott; Harvey D White; Jose C Nicolau; Ezio Bramucci; Sabina A Murphy; Marc P Bonaca; Christian T Ruff; Benjamin M Scirica; Carolyn H McCabe; Elliott M Antman; Eugene Braunwald
Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction.
Circulation 2009;119(21):2758-64.
2009: Roxana Mehran; Stuart J Pocock; Gregg W Stone; Tim C Clayton; George D Dangas; Frederick Feit; Steven V Manoukian; Eugenia Nikolsky; Alexandra J Lansky; Ajay Kirtane; Harvey D White; Antonio Colombo; James H Ware; Jeffrey W Moses; Erik Ohman
Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial.
European heart journal 2009;30(12):1457-66.
2009: C Berry; Karen S Pieper; Harvey D White; Scott D Solomon; Frans Van de Werf; Eric J Velazquez; Aldo P Maggioni; Robert M Califf; Marc A Pfeffer; John J V McMurray
Patients with prior coronary artery bypass grafting have a poor outcome after myocardial infarction: an analysis of the VALsartan in acute myocardial iNfarcTion trial (VALIANT).
European heart journal 2009;30(12):1450-6.
2009: Edward F Ewen; Liping Zhao; Paul Kolm; Claudine Jurkovitz; Dogan Fidan; Harvey D White; Richard Gallo; William S Weintraub
Determining the in-hospital cost of bleeding in patients undergoing percutaneous coronary intervention.
Journal of interventional cardiology 2009;22(3):266-73.
2009: Ramin Ebrahimi; Cornelius Dyke; Roxana Mehran; Steven V Manoukian; Frederick Feit; David A Cox; Bernard J Gersh; Erik Ohman; Harvey D White; Jeffrey W Moses; James H Ware; A Michael Lincoff; Gregg W Stone
Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
Journal of the American College of Cardiology 2009;53(21):1965-72.
2009: Harvey D White
Pharmacological and clinical profile of bivalirudin in the treatment of patients with acute coronary syndrome.
Expert opinion on drug metabolism & toxicology 2009;5(5):529-38.
2009: Alexandra J Lansky; Roxana Mehran; Ecatarina Cristea; Helen Parise; Frederick Feit; Erik Ohman; Harvey D White; Karen P Alexander; Michel E Bertrand; Walter Desmet; Martial Hamon; Gregg W Stone
Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial).
The American journal of cardiology 2009;103(9):1196-203.
2009: Paul W Armstrong; Yuling Fu; Cynthia M Westerhout; Michael P Hudson; Kenneth W Mahaffey; Harvey D White; Thomas G Todaro; Peter X Adams; Philip E G Aylward; Christopher B Granger
Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
Journal of the American College of Cardiology 2009;53(17):1503-9.
2009: Tracy Y Wang; Min Zhang; Yuling Fu; Paul W Armstrong; L Kristin Newby; C Michael Gibson; David J Moliterno; Frans Van de Werf; Harvey D White; Robert A Harrington; Matthew T Roe
Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non-ST-elevation acute coronary syndromes undergoing diagnostic angiography.
American heart journal 2009;157(4):716-23.
2009: Renato D Lopes; Karen P Alexander; Steven V Manoukian; Michel E Bertrand; Frederick Feit; Harvey D White; Charles V Pollack; James Hoekstra; Bernard J Gersh; Gregg W Stone; Erik Ohman
Advanced age, antithrombotic strategy, and bleeding in non-ST-segment elevation acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
Journal of the American College of Cardiology 2009;53(12):1021-30.
2009: Richard Gallo; Steven R Steinhubl; Harvey D White; Gilles Montalescot
Impact of anticoagulation regimens on sheath management and bleeding in patients undergoing elective percutaneous coronary intervention in the STEEPLE trial.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2009;73(3):319-25.
2009: Jiro Aoki; Alexandra J Lansky; Roxana Mehran; Jeffery Moses; Michel E Bertrand; Brent T McLaurin; David A Cox; A Michael Lincoff; Erik Ohman; Harvey D White; Helen Parise; Martin B Leon; Gregg W Stone
Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial.
Circulation 2009;119(5):687-98.
2009: Harvey D White
HORIZONS trial: a step forward for primary percutaneous coronary intervention.
Expert review of cardiovascular therapy 2009;7(2):125-9.
2009: Cheuk-Kit Wong; W Gao; Ralph A H Stewart; John K French; Philip E G Aylward; Harvey D White
Relationship of QRS duration at baseline and changes over 60 min after fibrinolysis to 30-day mortality with different locations of ST elevation myocardial infarction: results from the Hirulog and Early Reperfusion or Occlusion-2 trial.
Heart (British Cardiac Society) 2009;95(4):276-82.
2009: Venu Menon; Camille A Pearte; Christopher E Buller; Philippe Gabriel STEG; Sandra A Forman; Harvey D White; Paolo N Marino; Demosthenes G Katritsis; Paulo Caramori; Ricardo Lasevitch; Krystyna Loboz-Grudzien; Aleksander Zurakowski; Gervasio A Lamas; Judith S Hochman
Lack of benefit from percutaneous intervention of persistently occluded infarct arteries after the acute phase of myocardial infarction is time independent: insights from Occluded Artery Trial.
European heart journal 2009;30(2):183-91.
2008: Jonathan Piccini; Patrick M Hranitzky; Rakhi Kilaru; Jean-Lucien Rouleau; Harvey D White; Philip E Aylward; Frans Van de Werf; Scott D Solomon; Robert M Califf; Eric J Velazquez
Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
The American journal of cardiology 2008;102(11):1427-32.
2008: Andrew C Y To; Khang Li Looi; Dragan Damianovich; Graeme B Taylor; David Sidebotham; Harvey D White
A case of cardiogenic shock caused by capecitabine treatment.
Nature clinical practice. Cardiovascular medicine 2008;5(11):725-9.
2008: Joseph S Alpert; Kristian Thygesen; Harvey D White; Allan S Jaffe
Implications of the universal definition of myocardial infarction.
Nature clinical practice. Cardiovascular medicine 2008;5(11):678-9.
2008: Mariusz Kruk; Jacek Kadziela; Harmony R Reynolds; Sandra A Forman; Zygmunt Sadowski; Bruce A Barton; Daniel B Mark; Aldo P Maggioni; Jonathan Leor; John G Webb; Michael Kapeliovich; Jose A Marin-Neto; Harvey D White; Gervasio A Lamas; Judith S Hochman
Predictors of outcome and the lack of effect of percutaneous coronary intervention across the risk strata in patients with persistent total occlusion after myocardial infarction: Results from the OAT (Occluded Artery Trial) study.
JACC. Cardiovascular interventions 2008;1(5):511-20.
2008: Joseph S Alpert; Kristian Thygesen; Allan Jaffe; Harvey D White
The universal definition of myocardial infarction: a consensus document: ischaemic heart disease.
Heart (British Cardiac Society) 2008;94(10):1335-41.
2008: Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Harvey D White
Diagnostic application of the universal definition of myocardial infarction in the intensive care unit.
Current opinion in critical care 2008;14(5):543-8.
2008: Christopher E Buller; Yuling Fu; Kenneth W Mahaffey; Thomas G Todaro; Peter Adams; Cynthia M Westerhout; Harvey D White; Arnoud W J van 't Hof; Frans J Van de Werf; Galen S Wagner; Christopher B Granger; Paul W Armstrong
ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
Circulation 2008;118(13):1335-46.
2008: Harvey D White; Erik Ohman; A Michael Lincoff; Michel E Bertrand; Antonio Colombo; Brent T McLaurin; David A Cox; Stuart J Pocock; James A Ware; Steven V Manoukian; Alexandra J Lansky; Roxana Mehran; Jeffrey W Moses; Gregg W Stone
Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
Journal of the American College of Cardiology 2008;52(10):807-14.
2008: Harvey D White; Derek P Chew
Acute myocardial infarction.
Lancet 2008;372(9638):570-84.
2008: Mark Y Chan; Kenneth W Mahaffey; Lena J Sun; Karen S Pieper; Harvey D White; Philip E Aylward; James J Ferguson; Robert M Califf; Matthew T Roe
Prevalence, predictors, and impact of conservative medical management for patients with non-ST-segment elevation acute coronary syndromes who have angiographically documented significant coronary disease.
JACC. Cardiovascular interventions 2008;1(4):369-78.
2008: Ralph A H Stewart; Andrew J Kerr; Brett R Cowan; Alistair A Young; Christopher Occleshaw; A Mark Richards; Colin Edwards; Gillian Whalley; Denis Freidlander; Miles Williams; Robert N Doughty; Irene Zeng; Harvey D White
A randomized trial of the aldosterone-receptor antagonist eplerenone in asymptomatic moderate-severe aortic stenosis.
American heart journal 2008;156(2):348-55.
2008: Renato D Lopes; Karen P Alexander; Gretchen Marcucci; Harvey D White; Sarah Spinler; Jacques Col; Philip E Aylward; Robert M Califf; Kenneth W Mahaffey
Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial.
European heart journal 2008;29(15):1827-33.
2008: Harvey D White
Systems of care: need for hub-and-spoke systems for both primary and systematic percutaneous coronary intervention after fibrinolysis.
Circulation 2008;118(3):219-22.
2008: Harvey D White
Will new higher-precision troponins lead to clarity or confusion?
Current opinion in cardiology 2008;23(4):292-5.
2008: R D Lopes; K S Pieper; J R Horton; Sana M Al-Khatib; L Kristin Newby; Rajendra H Mehta; Frans Van de Werf; Paul W Armstrong; K W Mahaffey; Robert A Harrington; Erik Ohman; Harvey D White; Lars Wallentin; Christopher B Granger
Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation.
Heart (British Cardiac Society) 2008;94(7):867-73.
2008: Harvey D White
Evolution of the definition of myocardial infarction: what are the implications of a new universal definition?
Heart (British Cardiac Society) 2008;94(6):679-84.
2008: Harvey D White; Derek P Chew; James W Hoekstra; Chadwick D Miller; Charles V Pollack; Frederick Feit; A Michael Lincoff; Michel Bertrand; Stuart Pocock; James Ware; Erik Ohman; Roxana Mehran; Gregg W Stone
Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
Journal of the American College of Cardiology 2008;51(18):1734-41.
2008: Derek P Chew; Kenneth W Mahaffey; Harvey D White; Zhen Huang; James W Hoekstra; James J Ferguson; Robert M Califf; Philip E Aylward
Coronary artery bypass surgery in patients with acute coronary syndromes is difficult to predict.
American heart journal 2008;155(5):841-7.
2008: Rachel E Anderson; Marc A Pfeffer; Jens jakob Thune; John J V McMurray; Robert M Califf; Eric J Velazquez; Harvey D White; Jean-Lucien Rouleau; Hicham Skali; Aldo Maggioni; Scott D Solomon
High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
American heart journal 2008;155(4):706-11.
2008: Rajendra H Mehta; Sunil V Rao; Erik Ohman; Eric R Bates; Gretchen Marcucci; Min Zhang; Karen S Pieper; Paul W Armstrong; Harvey D White; Frans Van de Werf; Robert M Califf; Christopher B Granger
Variation in the use of stress testing and outcomes in patients with non-ST-elevation acute coronary syndromes: insights from GUSTO IIb.
European heart journal 2008;29(7):880-7.
2008: Malcolm J West; Paul J Nestel; Adrienne C Kirby; Renate Schnabel; David Sullivan; R John Simes; Christine Pollicino; Edith Lubos; Thomas Münzel; Harvey D White; Andrew M Tonkin; Christoph Bickel; Laurence Tiret; Stefan Blankenberg
The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study.
European heart journal 2008;29(7):923-31.
2008: Harvey D White; Anthony J Dalby
Heart disease in Soweto: facing a triple threat.
Lancet 2008;371(9616):876-7.
2008: Kenneth W Mahaffey; Qinghong Yang; Karen S Pieper; Elliott M Antman; Harvey D White; Shaun G Goodman; Marc Cohen; Neal S Kleiman; Anatoly Langer; Philip E G Aylward; Jacques J Col; Craig J Reist; James J Ferguson; Robert M Califf
Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial.
Journal of general internal medicine 2008;23(3):310-6.
2008: Ralph A H Stewart; Fiona M North; Katrina J Sharples; R John Simes; Andrew M Tonkin; Harvey D White
Differences in cardiovascular mortality between Australia and New Zealand according to socioeconomic status: findings from the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study.
The New Zealand medical journal 2008;121(1269):11-23.
2008: Gilles Montalescot; Marc Cohen; Genevieve Salette; Walter J Desmet; Carlos Macaya; Philip E G Aylward; Philippe Gabriel STEG; Harvey D White; Richard Gallo; Steven R Steinhubl
Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: insights from the STEEPLE trial.
European heart journal 2008;29(4):462-71.
2008: Jeffrey S Berger; Amanda L Stebbins; Christopher B Granger; Erik Ohman; Paul W Armstrong; Frans Van de Werf; Harvey D White; R John Simes; Robert A Harrington; Robert M Califf; Eric D Peterson
Initial aspirin dose and outcome among ST-elevation myocardial infarction patients treated with fibrinolytic therapy.
Circulation 2008;117(2):192-9.
2008: Sunil V Rao; Karen Chiswell; Jie Lena Sun; Christopher B Granger; L Kristin Newby; Frans Van de Werf; Harvey D White; Paul W Armstong; Robert M Califf; Robert A Harrington
International variation in the use of blood transfusion in patients with non-ST-segment elevation acute coronary syndromes.
The American journal of cardiology 2008;101(1):25-29.
2007: Raphaelle Dumaine; Maria Borentain; Osmund Bertel; Christoph Bode; Richard Gallo; Harvey D White; Jean-Philippe Collet; Steven R Steinhubl; Gilles Montalescot
Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials.
Archives of internal medicine 2007;167(22):2423-30.
2007: Gregg W Stone; James H Ware; Michel E Bertrand; A Michael Lincoff; Jeffrey W Moses; Erik Ohman; Harvey D White; Frederick Feit; Antonio Colombo; Brent T McLaurin; David A Cox; Steven V Manoukian; Martin Fahy; Tim C Clayton; Roxana Mehran; Stuart J Pocock
Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial.
JAMA : the journal of the American Medical Association 2007;298(21):2497-506.
2007: Pierluigi Tricoci; Yuliya Lokhnygina; Lisa G Berdan; Steven R Steinhubl; Dietrich C Gulba; Harvey D White; Neal S Kleiman; Philip E G Aylward; Anatoly Langer; Robert M Califf; James J Ferguson; Elliott M Antman; L Kristin Newby; Robert A Harrington; Shaun G Goodman; Kenneth W Mahaffey
Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
Circulation 2007;116(23):2669-77.
2007: Kristian Thygesen; Joseph S Alpert; Harvey D White
Universal definition of myocardial infarction.
Journal of the American College of Cardiology 2007;50(22):2173-95.
2007: Daniel B Mark; Frans Van de Werf; R John Simes; Harvey D White; Lars Wallentin; Robert M Califf; Paul W Armstrong
Cardiovascular disease on a global scale: defining the path forward for research and practice.
European heart journal 2007;28(21):2678-84.
2007: Kristian Thygesen; Joseph S Alpert; Harvey D White
Universal definition of myocardial infarction.
European heart journal 2007;28(20):2525-38.
2007: Cheuk-Kit Wong; Harvey D White
Elderly patients should not be denied fibrinolytic therapy.
Nature clinical practice. Cardiovascular medicine 2007;4(10):520-1.
2007: Ruvin S Gabriel; Harvey D White
ExTRACT-TIMI 25 trial: clarifying the role of enoxaparin in patients with ST-elevation myocardial infarction receiving fibrinolysis.
Expert review of cardiovascular therapy 2007;5(5):851-7.
2007: Cheuk-Kit Wong; L Kristin Newby; Manju V Bhapker; Phil E Aylward; Matthias Pfisterer; Karen P Alexander; Paul W Armstrong; Judith S Hochman; Frans Van de Werf; Robert M Califf; Harvey D White
Use of evidence-based medicine for acute coronary syndromes in the elderly and very elderly: insights from the Sibrafiban vs aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes trials.
American heart journal 2007;154(2):313-21.
2007: John J Edmond; John K French; Philip E G Aylward; Cheuk-Kit Wong; Ralph A H Stewart; Barbara F Williams; Carmine G De Pasquale; R L O'connell; K Van den Berg; Frans Van de Werf; R John Simes; Harvey D White
Variations in the use of emergency PCI for the treatment of re-infarction following intravenous fibrinolytic therapy: impact on outcomes in HERO-2.
European heart journal 2007;28(12):1418-24.
2007: Karen P Alexander; L Kristin Newby; Paul W Armstrong; Christopher P Cannon; W Brian Gibler; Michael W Rich; Frans Van de Werf; Harvey D White; W Douglas Weaver; Mary D Naylor; Joel M Gore; Harlan Krumholz; Erik Ohman
Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Circulation 2007;115(19):2570-89.
2007: Karen P Alexander; L Kristin Newby; Christopher P Cannon; Paul W Armstrong; W Brian Gibler; Michael W Rich; Frans Van de Werf; Harvey D White; W Douglas Weaver; Mary D Naylor; Joel M Gore; Harlan Krumholz; Erik Ohman
Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Circulation 2007;115(19):2549-69.
2007: Harvey D White; Eugene Braunwald; Sabina A Murphy; Ashok J Jacob; Nina Gotcheva; Leonid Polonetsky; Elliott M Antman
Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25.
European heart journal 2007;28(9):1066-71.
2007: Steven V Manoukian; Frederick Feit; Roxana Mehran; Michele D Voeltz; Ramin Ebrahimi; Martial Hamon; George Dangas; A Michael Lincoff; Harvey D White; Jeffrey W Moses; Spencer B King; Erik Ohman; Gregg W Stone
Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial.
Journal of the American College of Cardiology 2007;49(12):1362-8.
2007: Gregg W Stone; Harvey D White; Erik Ohman; Michel E Bertrand; A Michael Lincoff; Brent T McLaurin; David A Cox; Stuart J Pocock; James H Ware; Frederick Feit; Antonio Colombo; Steven V Manoukian; Alexandra J Lansky; Roxana Mehran; Jeffrey W Moses
Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial.
Lancet 2007;369(9565):907-19.
2007: Rajendra H Mehta; Robert M Califf; Qinghong Yang; Karen S Pieper; Harvey D White; Erik Ohman; Robert A Harrington; Christopher B Granger
Impact of initial heart rate and systolic blood pressure on relation of age and mortality among fibrinolytic-treated patients with acute ST-elevation myocardial infarction presenting with cardiogenic shock.
The American journal of cardiology 2007;99(6):793-6.
2007: Kent Stephenson; Hicham Skali; john mcmurray; Eric J Velazquez; Philip G Aylward; Lars Kober; Frans Van de Werf; Harvey D White; Karen Pieper; Robert M Califf; Scott D Solomon; Marc A Pfeffer
Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: the VALIANT experience.
Heart rhythm : the official journal of the Heart Rhythm Society 2007;4(3):308-13.
2007: Uchechukwu Kachi Amakwenta Sampson; Marc A Pfeffer; john mcmurray; Yuliya Lokhnygina; Harvey D White; Scott D Solomon
Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT Trial.
European heart journal 2007;28(6):685-91.
2007: Gregg W Stone; Michel E Bertrand; Jeffrey W Moses; Erik Ohman; A Michael Lincoff; James H Ware; Stuart J Pocock; Brent T McLaurin; David A Cox; M Zubair Jafar; Harish Chandna; Franz Hartmann; Franz Leisch; Ruth H Strasser; Martin Desaga; Thomas D Stuckey; Richard B Zelman; Ira H Lieber; David J Cohen; Roxana Mehran; Harvey D White
Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial.
JAMA : the journal of the American Medical Association 2007;297(6):591-602.
2007: Harvey D White; Michael Gruber; Jan Feyzi; Scott S Kaatz; Hung-Fat Tse; Steen Husted; Gregory W Albers
Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V.
Archives of internal medicine 2007;167(3):239-45.
2007: Rajendra H Mehta; Robert M Califf; Jyotsna Garg; Harvey D White; Frans Van de Werf; Paul W Armstrong; Karen S Pieper; Eric J Topol; Christopher B Granger
The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarction.
European heart journal 2007;28(4):415-24.
2007: Ralph A Stewart; Harvey D White
Reducing the lifetime cardiovascular risk of New Zealanders.
The New Zealand medical journal 2007;120(1261):U2708.
2007: Cheuk-Kit Wong; Harvey D White
Direct antithrombins: mechanisms, trials, and role in contemporary interventional medicine.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2007;7(4):249-57.
2007: Christopher J K Hammett; Harry Prapavessis; James C Baldi; Rohan Ameratunga; Uwe Schoenbeck; Nerea Varo; John K French; Harvey D White; Ralph A H Stewart
Variation in blood levels of inflammatory markers related and unrelated to smoking cessation in women.
Preventive cardiology 2007;10(2):68-75.
2007: Robert N Doughty; Harvey D White
Carvedilol: use in chronic heart failure.
Expert review of cardiovascular therapy 2007;5(1):21-31.
2007: Hendrik-Jan Dieker; John K French; Irene C Joziasse; Marc A Brouwer; John Elliott; Teena West; Bruce John Webber; Freek W A Verheugt; Harvey D White
Antiplatelet therapy and progression of coronary artery disease: a placebo-controlled trial with angiographic and clinical follow-up after myocardial infarction.
American heart journal 2007;153(1):66.e1-8.
2007: Warren J Cantor; Kenneth W Mahaffey; Zhen Huang; Pranab Das; Dietrich C Gulba; Stanislav Glezer; Richard Gallo; John Ducas; Marc Cohen; Elliott M Antman; Anatoly Langer; Neal S Kleiman; Harvey D White; Robert J Chisholm; Robert A Harrington; James J Ferguson; Robert M Califf; Shaun G Goodman
Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2007;69(1):73-83.
2006: Harvey D White; Neal S Kleiman; Kenneth W Mahaffey; Yuliya Lokhnygina; Karen S Pieper; Karen Chiswell; Marc Cohen; Robert A Harrington; Derek P Chew; John L Petersen; Lisa G Berdan; Philip E G Aylward; Christopher C. Nessel; James J Ferguson; Robert M Califf
Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial.
American heart journal 2006;152(6):1042-50.
2006: Gregg W Stone; Brent T McLaurin; David A Cox; Michel E Bertrand; A Michael Lincoff; Jeffrey W Moses; Harvey D White; Stuart J Pocock; James H Ware; Frederick Feit; Antonio Colombo; Philip E Aylward; Angel R Cequier; Harald Darius; Walter Desmet; Ramin Ebrahimi; Martial Hamon; Lars H Rasmussen; Hans-Jürgen Rupprecht; James Hoekstra; Roxana Mehran; Erik Ohman
Bivalirudin for patients with acute coronary syndromes.
The New England journal of medicine 2006;355(21):2203-16.
2006: Marc Cohen; Kenneth W Mahaffey; Karen Pieper; Charles V Pollack; Elliott M Antman; James Hoekstra; Shaun G Goodman; Anatoly Langer; Jacques J Col; Harvey D White; Robert M Califf; James J Ferguson
A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes.
Journal of the American College of Cardiology 2006;48(7):1346-54.
2006: Gilles Montalescot; Harvey D White; Richard Gallo; Marc Cohen; Philippe Gabriel STEG; Philip E G Aylward; Christoph Bode; Massimo Chiariello; Spencer B King; Robert A Harrington; Walter Desmet; Carlos Macaya; Steven R Steinhubl
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention.
The New England journal of medicine 2006;355(10):1006-17.
2006: Shelby D Reed; john mcmurray; Eric J Velazquez; Kevin Schulman; Robert M Califf; Lars Kober; Aldo P Maggioni; Frans Van de Werf; Harvey D White; Rafael Diaz; Viatcheslav Mareev; Jan Murin
Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
American heart journal 2006;152(3):500-8.
2006: Cheuk-Kit Wong; Wanzhen Gao; Ralph A H Stewart; Niels van Pelt; John K French; Philip E G Aylward; Harvey D White
Risk stratification of patients with acute anterior myocardial infarction and right bundle-branch block: importance of QRS duration and early ST-segment resolution after fibrinolytic therapy.
Circulation 2006;114(8):783-9.
2006: Rajesh Janardhanan; Satish Kenchaiah; Eric J Velazquez; Yuhyun Park; john mcmurray; W Douglas Weaver; Peter V Finn; Harvey D White; José Antonio Marin-Neto; Chris O'Connor; Marc A Pfeffer; Robert M Califf; Scott D Solomon
Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
American heart journal 2006;152(1):183-9.
2006: Karen P Alexander; L Kristin Newby; Manjushri Bhapkar; Harvey D White; Judith S Hochman; Matthias E Pfisterer; David J Moliterno; eric peterson; Frans Van de Werf; Paul W Armstrong; Robert M Califf
International variation in invasive care of the elderly with acute coronary syndromes.
European heart journal 2006;27(13):1558-64.
2006: Cheuk-Kit Wong; Wanzhen Gao; O Christopher Raffel; John K French; Ralph A H Stewart; Harvey D White
Initial Q waves accompanying ST-segment elevation at presentation of acute myocardial infarction and 30-day mortality in patients given streptokinase therapy: an analysis from HERO-2.
Lancet 2006;367(9528):2061-7.
2006: Judith S Hochman; Lynn A Sleeper; John G Webb; Vladimir Dzavik; Christopher E Buller; Philip E G Aylward; Jacques Col; Harvey D White
Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction.
JAMA : the journal of the American Medical Association 2006;295(21):2511-5.
2006: O Christopher Raffel; Harvey D White
Drug insight: Statin use in the elderly.
Nature clinical practice. Cardiovascular medicine 2006;3(6):318-28.
2006: Cheryl D Bushnell; Jeffrey Griffin; L Kristin Newby; Larry B Goldstein; Kenneth W Mahaffey; Carmelo Graffagnino; Robert A Harrington; Harvey D White; R John Simes; Robert M Califf; Eric J Topol; J Donald Easton
Statin use and sex-specific stroke outcomes in patients with vascular disease.
Stroke; a journal of cerebral circulation 2006;37(6):1427-31.
2006: Elliott M Antman; David A Morrow; Carolyn H McCabe; Sabina A Murphy; Mikhail Ruda; Zygmunt Sadowski; Andrzej Budaj; Jose L López-Sendón; Sema Guneri; Frank Jiang; Harvey D White; Keith A A Fox; Eugene Braunwald
Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction.
The New England journal of medicine 2006;354(14):1477-88.
2006: Harmony R Reynolds; Sumeet K Anand; Justin M Fox; Shannon M Harkness; Vladimir Dzavik; Harvey D White; John G Webb; Kenneth Gin; Judith S Hochman; Michael H Picard
Restrictive physiology in cardiogenic shock: observations from echocardiography.
American heart journal 2006;151(4):890.e9-15.
2006: John J Edmond; John K French; Ralph A H Stewart; Philip A Aylward; Carmine G De Pasquale; Barbara F Williams; Rachel L O'Connell; R John Simes; Harvey D White
Frequency of recurrent ST-elevation myocardial infarction after fibrinolytic therapy in a different territory as a manifestation of multiple unstable coronary arterial plaques.
The American journal of cardiology 2006;97(7):947-51.
2006: Christopher J K Hammett; Harry Prapavessis; James C Baldi; Nerea Varo; Uwe Schoenbeck; Rohan Ameratunga; John K French; Harvey D White; Ralph A H Stewart
Effects of exercise training on 5 inflammatory markers associated with cardiovascular risk.
American heart journal 2006;151(2):367.e7-367.e16.
2006: Rajendra H Mehta; David Marks; Robert M Califf; SeeHyang Sohn; Karen S Pieper; Frans Van de Werf; Eric D Peterson; Erik Ohman; Harvey D White; Eric J Topol; Christopher B Granger
Differences in the clinical features and outcomes in African Americans and whites with myocardial infarction.
The American journal of medicine 2006;119(1):70.e1-8.
2006: Teresa L Kauf; Eric J Velazquez; David R Crosslin; W Douglas Weaver; Rafael Diaz; Christopher B Granger; john mcmurray; Jean-Lucien Rouleau; Philip E Aylward; Harvey D White; Robert M Califf; Kevin Schulman
The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry.
American heart journal 2006;151(1):206-12.
2006: John M Galla; Kenneth W Mahaffey; Shelly K Sapp; John H Alexander; Matthew T Roe; Erik Ohman; Christopher B Granger; Paul W Armstrong; Robert A Harrington; Harvey D White; Maarten L Simoons; L Kristin Newby; Robert M Califf; Eric J Topol
Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials.
American heart journal 2006;151(1):16-24.
2006: Cheuk-Kit Wong; Ralph A H Stewart; Wanzhen Gao; John K French; Christopher Raffel; Harvey D White
Prognostic differences between different types of bundle branch block during the early phase of acute myocardial infarction: insights from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial.
European heart journal 2006;27(1):21-8.
2005: David A Morrow; James A de Lemos; Michael A Blazing; Marc S Sabatine; Sabina A Murphy; Petr Jarolim; Harvey D White; Keith A A Fox; Robert M Califf; Eugene Braunwald
Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease.
JAMA : the journal of the American Medical Association 2005;294(22):2866-71.
2005: Harvey D White
Adherence and outcomes: it's more than taking the pills.
Lancet 2005;366(9502):1989-91.
2005: Harvey D White; Philip E G Aylward; Zhen Huang; Anthony J Dalby; W Douglas Weaver; Ståle Barvik; José Antonio Marin-Neto; Jan Murin; Rolf O Nordlander; Wiek H van Gilst; Faiez Zannad; john mcmurray; Robert M Califf; Marc A Pfeffer
Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Circulation 2005;112(22):3391-9.
2005: Kenneth W Mahaffey; Marc Cohen; Jyotsna Garg; Elliott M Antman; Neal S Kleiman; Shaun G Goodman; Lisa G Berdan; Craig J Reist; Anatoly Langer; Harvey D White; Philip E G Aylward; Jacques J Col; James J Ferguson; Robert M Califf
High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial.
JAMA : the journal of the American Medical Association 2005;294(20):2594-600.
2005: Judith S Hochman; Gervasio A Lamas; Genell L Knatterud; Christopher E Buller; Vladimir Dzavik; Daniel B Mark; Harmony R Reynolds; Harvey D White
Design and methodology of the Occluded Artery Trial (OAT).
American heart journal 2005;150(4):627-42.
2005: Karolina E Szummer; Scott D Solomon; Eric J Velazquez; Rakhi Kilaru; John McMurray; Jean-Lucien Rouleau; Kenneth W Mahaffey; Aldo P Maggioni; Robert M Califf; Marc A Pfeffer; Harvey D White
Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registry.
European heart journal 2005;26(20):2114-9.
2005: Harvey D White; Susan F Assmann; Timothy A Sanborn; Alice K Jacobs; John G Webb; Lynn A Sleeper; Cheuk-Kit Wong; James T Stewart; Philip E G Aylward; S Chiu Wong; Judith S Hochman
Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial.
Circulation 2005;112(13):1992-2001.
2005: Cheuk-Kit Wong; Harvey D White
Should bivalirudin be the anticoagulant of choice for percutaneous coronary intervention?
Nature clinical practice. Cardiovascular medicine 2005;2(8):384-5.
2005: Brahmajee K Nallamothu; Eric R Bates; Judith S Hochman; Christopher B Granger; Victor Guetta; Robert G Wilcox; Harvey D White; Paul W Armstrong; Stefano Savonitto; Gang Jia; A Michael Lincoff; Eric J Topol
Prognostic implication of activated partial thromboplastin time after reteplase or half-dose reteplase plus abciximab: results from the GUSTO-V trial.
European heart journal 2005;26(15):1506-12.
2005: Lynn A Sleeper; Krishnan Ramanathan; Michael H Picard; Thierry H LeJemtel; Harvey D White; Vladimir Dzavik; Deborah Tormey; Nancy E Avis; Judith S Hochman
Functional status and quality of life after emergency revascularization for cardiogenic shock complicating acute myocardial infarction.
Journal of the American College of Cardiology 2005;46(2):266-73.
2005: Cheuk-Kit Wong; John K French; Philip E G Aylward; Ralph A H Stewart; Wanzhen Gao; Paul W Armstrong; Frans J J Van De Werf; R John Simes; O Christopher Raffel; Christopher B Granger; Robert M Califf; Harvey D White
Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes.
Journal of the American College of Cardiology 2005;46(1):29-38.
2005: Sorin J Brener; A Michael Lincoff; Eric R Bates; Gang Jia; Paul W Armstrong; Victor Guetta; Judith S Hochman; Stefano Savonitto; Robert G Wilcox; Harvey D White; Eric J Topol
The relationship between baseline risk and mortality in ST-elevation acute myocardial infarction treated with pharmacological reperfusion: insights from the Global Utilization of Strategies To open Occluded arteries (GUSTO) V trial.
American heart journal 2005;150(1):89-93.
2005: Derek P Chew; Philip E G Aylward; Harvey D White
Facilitated percutaneous coronary intervention: is this strategy ready for implementation?
Current cardiology reports 2005;7(4):235-41.
2005: Kenneth W Mahaffey; Matthew T Roe; Rakhi Kilaru; John K French; John H Alexander; Lisa G Berdan; Frans Van de Werf; Maarten L Simoons; W Douglas Weaver; Harvey D White; A Michael Lincoff; Neal S Kleiman; Eric J Topol; Robert A Harrington
Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes.
The American journal of cardiology 2005;95(12):1404-8.
2005: Paul J Nestel; Katrine Baghurst; David M Colquhoun; R John Simes; Kirsty Mehalski; Harvey D White; Andrew M Tonkin; Adrienne Kirby; Christine Pollicino
Relation of diet to cardiovascular disease risk factors in subjects with cardiovascular disease in Australia and New Zealand: analysis of the Long-Term Intervention with Pravastatin in Ischaemic Disease trial.
The American journal of clinical nutrition 2005;81(6):1322-9.
2005: Lisa A Mendes; Michael H Picard; Lynn A Sleeper; Christopher Thompson; Alice K Jacobs; Harvey D White; Judith S Hochman; Ravin Davidoff
Cardiogenic shock: predictors of outcome based on right and left ventricular size and function at presentation.
Coronary artery disease 2005;16(4):209-15.
2005: Rajendra H Mehta; Robert M Califf; Jyotsna Garg; Karen S Pieper; John H Alexander; David J Moliterno; Frans Van de Werf; Erik Ohman; Harvey D White; Eric J Topol; Christopher B Granger
Association of height with outcomes in patients with acute myocardial infarction receiving reperfusion therapy.
The American journal of cardiology 2005;95(11):1371-5.
2005: Cheuk-Kit Wong; Harvey D White
Value of community-derived risk models for stratifying patients with non-ST elevation acute coronary syndromes.
European heart journal 2005;26(9):851-2.
2005: Ralph A H Stewart; Harvey D White; Adrienne C Kirby; Stephane Heritier; R John Simes; Paul J Nestel; Malcolm J West; David M Colquhoun; Andrew M Tonkin
White blood cell count predicts reduction in coronary heart disease mortality with pravastatin.
Circulation 2005;111(14):1756-62.
2005: Trip J Meine; Sana M Al-Khatib; John H Alexander; Christopher B Granger; Harvey D White; Rakhi Kilaru; Kathryn Williams; Erik Ohman; Eric J Topol; Robert M Califf
Incidence, predictors, and outcomes of high-degree atrioventricular block complicating acute myocardial infarction treated with thrombolytic therapy.
American heart journal 2005;149(4):670-4.
2005: Bernard J Gersh; Gregg W Stone; Harvey D White; David R Holmes
Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future?
JAMA : the journal of the American Medical Association 2005;293(8):979-86.
2005: Rajendra H Mehta; Christopher B Granger; Karen P Alexander; Eduardo Bossone; Harvey D White; Michael H Sketch
Reperfusion strategies for acute myocardial infarction in the elderly: benefits and risks.
Journal of the American College of Cardiology 2005;45(4):471-8.
2005: Elliott M Antman; David A Morrow; Carolyn H McCabe; Frank Jiang; Harvey D White; Keith A A Fox; Divakar Sharma; Paul Chew; Eugene Braunwald
Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25).
American heart journal 2005;149(2):217-26.
2005: Marino Labinaz; Jasmine Mathias; Karen S Pieper; Christopher B Granger; A Michael Lincoff; David J Moliterno; Frans Van de Werf; R John Simes; Harvey D White; Maarten L Simoons; Robert M Califf; Eric J Topol; Paul W Armstrong; Robert A Harrington
Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials.
European heart journal 2005;26(2):128-36.
2004: Christopher J K Hammett; Helen C Oxenham; James C Baldi; Robert N Doughty; Rohan Ameratunga; John K French; Harvey D White; Ralph A H Stewart
Effect of six months' exercise training on C-reactive protein levels in healthy elderly subjects.
Journal of the American College of Cardiology 2004;44(12):2411-3.
2004: Paul W Armstrong; L Kristin Newby; Christopher B Granger; Kerry L Lee; R John Simes; Frans Van de Werf; Harvey D White; Robert M Califf
Lessons learned from a clinical trial.
Circulation 2004;110(23):3610-4.
2004: Christopher Heeschen; Christian W Hamm; Veselin Mitrovic; Nicte-Ha Lantelme; Harvey D White
N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.
Circulation 2004;110(20):3206-12.
2004: Selwyn P Wong; John K French; Anna-Maria Lydon; Samuel O M Manda; Wanzhen Gao; Noel G Ashton; Harvey D White
Relation of left ventricular sphericity to 10-year survival after acute myocardial infarction.
The American journal of cardiology 2004;94(10):1270-5.
2004: Harvey D White; Sebastian T Palmeri; Lynn A Sleeper; John K French; Cheuk-Kit Wong; April M Lowe; Julia W Crapo; Patrick T Koller; Kenneth W Baran; Jean Boland; Judith S Hochman; Galen S Wagner
Electrocardiographic findings in cardiogenic shock, risk prediction, and the effects of emergency revascularization: results from the SHOCK trial.
American heart journal 2004;148(5):810-7.
2004: Gregg W Stone; Michel Bertrand; Antonio Colombo; George Dangas; Michael E Farkouh; Frederick Feit; Alexandra J Lansky; A Michael Lincoff; Roxana Mehran; Jeffrey W Moses; Magnus Ohman; Harvey D White
Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale.
American heart journal 2004;148(5):764-75.
2004: Eric J Velazquez; Gary S Francis; Paul W Armstrong; Philip E Aylward; Rafael Diaz; Christopher M O'Connor; Harvey D White; Marc Henis; Lois M Rittenhouse; Rakhi Kilaru; Wiek H van Gilst; Georg Ertl; Aldo P Maggioni; Jiri Spac; W Douglas Weaver; Jean-Lucien Rouleau; john mcmurray; Marc A Pfeffer; Robert M Califf
An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry.
European heart journal 2004;25(21):1911-9.
2004: Cheuk-Kit Wong; Christopher J K Hammett; R The; John K French; W Gao; Bruce John Webber; J M Elliott; A W Hamer; John A Ormiston; Mark W I Webster; Ralph A H Stewart; Rohan Ameratunga; Harvey D White
Lack of association between baseline plasma homocysteine concentrations and restenosis rates after a first elective percutaneous coronary intervention without stenting.
Heart (British Cardiac Society) 2004;90(11):1299-302.
2004: Elizabeth Parsons; L Kristin Newby; Manjushri Bhapkar; Karen P Alexander; Harvey D White; Svati H Shah; Cheryl D Bushnell; Robert M Califf
Postmenopausal hormone use in women with acute coronary syndromes.
Journal of women's health (2002) 2004;13(8):863-71.
2004: James A de Lemos; Michael A Blazing; Stephen D Wiviott; William E Brady; Harvey D White; Keith A A Fox; Joanne Palmisano; Karen E Ramsey; David W Bilheimer; Eldrin F Lewis; M Pfeffer; Robert M Califf; Eugene Braunwald
Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial.
European heart journal 2004;25(19):1688-94.
2004: Nagesh S Anavekar; john mcmurray; Eric J Velazquez; Scott D Solomon; Lars Kober; Jean-Lucien Rouleau; Harvey D White; Rolf Nordlander; Aldo Maggioni; Kenneth Dickstein; Steven Zelenkofske; Jeffrey D Leimberger; Robert M Califf; Marc A Pfeffer
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
The New England journal of medicine 2004;351(13):1285-95.
2004: James A de Lemos; Michael A Blazing; Stephen D Wiviott; Eldrin F Lewis; Keith A A Fox; Harvey D White; Jean-Lucien Rouleau; Terje R Pedersen; Laura H Gardner; Robin Mukherjee; Karen E Ramsey; Joanne Palmisano; David W Bilheimer; Marc A Pfeffer; Robert M Califf; Eugene Braunwald
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial.
JAMA : the journal of the American Medical Association 2004;292(11):1307-16.
2004: Hassan Kassem-Moussa; Kenneth W Mahaffey; Carmelo Graffagnino; Gudaye Tasissa; Cathy A Sila; R John Simes; Harvey D White; Robert M Califf; Manjushri Bhapkar; L Kristin Newby
Incidence and characteristics of stroke during 90-day follow-up in patients stabilized after an acute coronary syndrome.
American heart journal 2004;148(3):439-46.
2004: Michael A Blazing; James A de Lemos; Harvey D White; Keith A A Fox; Freek W A Verheugt; Diego Ardissino; Peter M DiBattiste; Joanne Palmisano; David W Bilheimer; Steven M Snapinn; Karen E Ramsey; Laura H Gardner; Vic Hasselblad; Marc A Pfeffer; Eldrin F Lewis; Eugene Braunwald; Robert M Califf
Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2004;292(1):55-64.
2004: Harvey D White
Heart, lung and circulation: flagship or millstone?
Heart, lung & circulation 2004;13(1):1-2.
2004: Alan Merry; Peter J Raudkivi; Neil G Middleton; John M McDougall; Parma Nand; Brigid P Mills; Bruce John Webber; Chris M Frampton; Harvey D White
Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery.
The Annals of thoracic surgery 2004;77(3):925-31; discussion 931.
2004: Harvey D White; James T Willerson
We must use the knowledge that we have to treat patients with acute coronary syndromes.
Circulation 2004;109(6):698-700.
2004: David E Kandzari; Christopher B Granger; Maarten L Simoons; Harvey D White; R John Simes; Kenneth W Mahaffey; Joel Gore; W Douglas Weaver; William T Longstreth; Amanda L Stebbins; Kerry L Lee; Robert M Califf; Eric J Topol
Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial).
The American journal of cardiology 2004;93(4):458-61.
2004: John K French; John J Edmond; Wanzhen Gao; Harvey D White; John W Eikelboom
Adjunctive use of direct thrombin inhibitors in patients receiving fibrinolytic therapy for acute myocardial infarction.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2004;4(2):107-15.
2004: John K French; Harvey D White
Clinical implications of the new definition of myocardial infarction.
Heart (British Cardiac Society) 2004;90(1):99-106.
2003: Claire McLintock; Robyn A North; Harvey D White
Prosthetic heart valves and pregnancy.
Circulation 2003;108(23):e159-60; author reply e159-60.
2003: Harvey D White; John K French
Use of brain natriuretic peptide levels for risk assessment in non-ST-elevation acute coronary syndromes.
Journal of the American College of Cardiology 2003;42(11):1917-20.
2003: L Kristin Newby; Manjushri Bhapkar; Harvey D White; David J Moliterno; Nancy M Allen LaPointe; David E Kandzari; Freek W A Verheugt; Judith M Kramer; Paul W Armstrong; Robert M Califf
Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation.
Journal of thrombosis and thrombolysis 2003;16(3):119-28.
2003: Judith M Kramer; L Kristin Newby; Wei Ching Chang; R John Simes; Frans Van de Werf; Christopher B Granger; Kerry L Lee; Harvey D White; Leopoldo Soares Piegas; Eric J Topol; Robert M Califf; Paul W Armstrong
International variation in the use of evidence-based medicines for acute coronary syndromes.
European heart journal 2003;24(23):2133-41.
2003: Ralph A H Stewart; Fiona M North; Teena West; Katrina J Sharples; R John Simes; David M Colquhoun; Harvey D White; Andrew M Tonkin
Depression and cardiovascular morbidity and mortality: cause or consequence?
European heart journal 2003;24(22):2027-37.
2003: Ivor L Gerber; Ralph A H Stewart; Christopher J K Hammett; Malcolm E Legget; Helen C Oxenham; Teena West; John K French; Harvey D White
Effect of aortic valve replacement on c-reactive protein in nonrheumatic aortic stenosis.
The American journal of cardiology 2003;92(9):1129-32.
2003: John G Webb; April M Lowe; Timothy A Sanborn; Harvey D White; Lynn A Sleeper; Ronald G Carere; Christopher E Buller; S Chiu Wong; Jean Boland; Vladimir Dzavik; Mark Porway; Gordon E Pate; Geoffrey Bergman; Judith S Hochman
Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial.
Journal of the American College of Cardiology 2003;42(8):1380-6.
2003: Marc Cohen; Andrea Alberto Conti; Frans Maritz; Enrique P Gurfinkel; Kurt Huber; Ari Timerman; Maria Krzeminska-Pakula; Nicolas Danchin; Harvey D White; Jose Santopinto; Frederique Bigonzi; Carole Hecquet; Luc Vittori
The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial.
Journal of the American College of Cardiology 2003;42(8):1348-56.
2003: Stefano Savonitto; P W Armstrong; A M Lincoff; G Jia; C A Sila; J Booth; P Terrosu; Claudio Cavallini; Harvey D White; Diego Ardissino; Robert M Califf; Eric J Topol
Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction. Dichotomous response as a function of age in the GUSTO V trial.
European heart journal 2003;24(20):1807-14.
2003: Ivor L Gerber; Ralph A H Stewart; John K French; Malcolm E Legget; Sally C Greaves; Teena West; Andrew J Kerr; A Mark Richards; Harvey D White
Associations between plasma natriuretic peptide levels, symptoms, and left ventricular function in patients with chronic aortic regurgitation.
The American journal of cardiology 2003;92(6):755-8.
2003: David F Kong; Vic Hasselblad; Robert A Harrington; Harvey D White; James E Tcheng; David E Kandzari; Eric J Topol; Robert M Califf
Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions.
The American journal of cardiology 2003;92(6):651-5.
2003: Harvey D White
Should all patients with coronary disease receive angiotensin-converting-enzyme inhibitors?
Lancet 2003;362(9386):755-7.
2003: Harvey D White
Candesartan and heart failure: the allure of CHARM.
Lancet 2003;362(9386):754-5.
2003: Cheuk-Kit Wong; Harvey D White; Robert G Wilcox; Douglas A Criger; Robert M Califf; Eric J Topol; Erik Ohman
Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial.
Cardiac electrophysiology review 2003;7(3):201-7.
2003: Eric J Velazquez; Marc A Pfeffer; John V McMurray; Aldo P Maggioni; Jean-Lucien Rouleau; Frans Van de Werf; Lars Kober; Harvey D White; Karl Swedberg; Jeffrey D Leimberger; Paul Gallo; Mary Ann Sellers; Susan Edwards; Marc Henis; Robert M Califf
VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context.
European journal of heart failure 2003;5(4):537-44.
2003: Thaddeus R Tolleson; L Kristin Newby; Robert A Harrington; Manjushri Bhapkar; Freek W A Verheugt; Peter B Berger; David J Moliterno; Harvey D White; Erik Ohman; Frans Van de Werf; Eric J Topol; Robert M Califf
Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials).
The American journal of cardiology 2003;92(3):330-3.
2003: Cheuk-Kit Wong; Harvey D White
Myocardial infarction: why can't we get the diagnosis right?
European heart journal 2003;24(13):1177-9.
2003: TA Hyde; John K French; C-K Wong; C Edwards; R M L Whitlock; Harvey D White
Associations between ST depression, four year mortality, and in-hospital revascularisation in unselected patients with non-ST elevation acute coronary syndromes.
Heart (British Cardiac Society) 2003;89(5):490-5.
2003: Ivor L Gerber; Ralph A H Stewart; Malcolm E Legget; Teena West; Renelle L French; Timothy M Sutton; Timothy G Yandle; John K French; A Mark Richards; Harvey D White
Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis.
Circulation 2003;107(14):1884-90.
2003: Barbara F Williams; John K French; Harvey D White
Informed consent during the clinical emergency of acute myocardial infarction (HERO-2 consent substudy): a prospective observational study.
Lancet 2003;361(9361):918-22.
2003: Sana M Al-Khatib; Amanda L Stebbins; Robert M Califf; Kerry L Lee; Christopher B Granger; Harvey D White; Paul W Armstrong; Eric J Topol; Erik Ohman
Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial.
American heart journal 2003;145(3):515-21.
2003: John K French; Krishnan Ramanathan; James T Stewart; Wanzhen Gao; Pierre Théroux; Harvey D White
A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction.
American heart journal 2003;145(3):508-14.
2003: Christopher Heeschen; Christian W Hamm; Ulrich Laufs; Michael Böhm; Steven M Snapinn; Harvey D White
Withdrawal of statins in patients with acute coronary syndromes.
Circulation 2003;107(3):e27.
2003: Michael H Picard; Ravin Davidoff; Lynn A Sleeper; Lisa A Mendes; Christopher Thompson; Vladimir Dzavik; Richard M Steingart; Kenneth Gin; Harvey D White; Judith S Hochman
Echocardiographic predictors of survival and response to early revascularization in cardiogenic shock.
Circulation 2003;107(2):279-84.
2003: L Kristin Newby; Manjushri Bhapkar; Harvey D White; Eric J Topol; F C Dougherty; Robert A Harrington; M C Smith; L F Asarch; Robert M Califf
Predictors of 90-day outcome in patients stabilized after acute coronary syndromes.
European heart journal 2003;24(2):172-81.
2003: John K French; Neil Van de Water; Timothy M Sutton; Mayanna Lund; WanZhen Gao; Joanne McDowell; Yiwen Liu-Stratton; Jeanette Pohorence; Diane Szymanski; Pascal J Goldschmidt-Clermont; Harvey D White; Peter Browett; Glen Cooke
Potential thrombophilic mutations/polymorphisms in patients with no flow-limiting stenosis after myocardial infarction.
American heart journal 2003;145(1):118-24.
2003: Cheuk-Kit Wong; John K French; Wanzhen Gao; Harvey D White
Relationship between initial white blood cell counts, stage of acute myocardial infarction evolution at presentation, and incidence of Thrombolysis In Myocardial Infarction-3 flow after streptokinase.
American heart journal 2003;145(1):95-102.
2002: J Conor O'Shea; Robert G Wilcox; Allan M Skene; Amanda L Stebbins; Christopher B Granger; Paul W Armstrong; Christoph Bode; Diego Ardissino; Hakan Emanuelsson; Philip E Aylward; Harvey D White; Zygmunt Sadowski; Eric J Topol; Robert M Califf; Erik Ohman
Comparison of outcomes of patients with myocardial infarction when living alone versus those not living alone.
The American journal of cardiology 2002;90(12):1374-7.
2002: Debabrata Mukherjee; Kenneth W Mahaffey; David J Moliterno; Robert A Harrington; Jay S Yadav; Karen S Pieper; Dianne Gallup; Christopher Dyke; Matthew T Roe; Lisa G Berdan; Michael Lauer; Matti Mänttäri; Harvey D White; Robert M Califf; Eric J Topol
Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B).
American heart journal 2002;144(6):995-1002.
2002: Harvey D White
Things ain't what they used to be: impact of a new definition of myocardial infarction.
American heart journal 2002;144(6):933-7.
2002: Malcolm J West; Harvey D White; R John Simes; Adrienne Kirby; John D Watson; Neil E Anderson; Graeme J Hankey; Susan Wonders; David Hunt; Andrew M Tonkin
Risk factors for non-haemorrhagic stroke in patients with coronary heart disease and the effect of lipid-modifying therapy with pravastatin.
Journal of hypertension 2002;20(12):2513-7.
2002: A Michael Lincoff; Robert M Califf; Frans Van de Werf; James T Willerson; Harvey D White; Paul W Armstrong; Victor Guetta; W Brian Gibler; Judith S Hochman; Christoph Bode; Alec Vahanian; Philippe Gabriel STEG; Diego Ardissino; Stefano Savonitto; Frits Bar; Zygmunt Sadowski; Amadeo Betriu; Joan E Booth; Kathy Wolski; Michael Waller; Eric J Topol
Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial.
JAMA : the journal of the American Medical Association 2002;288(17):2130-5.
2002: Colin Edwards; Ralph A H Stewart; Krishnan Ramanathan; Teena West; John K French; Harvey D White
Increased myocardial ischemia after food is not explained by endothelial dysfunction.
American heart journal 2002;144(5):E8.
2002: Paul Glasziou; Simon D Eckermann; Sarah E Mulray; R John Simes; Andrew J Martin; Adrienne C Kirby; Jane P Hall; Susan Caleo; Harvey D White; Andrew M Tonkin
Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: is it cost-effective?
The Medical journal of Australia 2002;177(8):428-34.
2002: Cheuk-Kit Wong; Harvey D White; Robert G Wilcox; Douglas A Criger; Robert M Califf; Eric J Topol; Erik Ohman
Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries.
Heart (British Cardiac Society) 2002;88(4):357-62.
2002: Marc Cohen; Pierre Théroux; Steven Borzak; Martin J Frey; Harvey D White; W Van Mieghem; Fred Senatore; Joy Lis; Robin Mukherjee; Kathy Harris; Frederique Bigonzi
Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin.
American heart journal 2002;144(3):470-7.
2002: Cheuk-Kit Wong; John K French; M W Krucoff; Wanzhen Gao; Philip E G Aylward; Harvey D White
Slowed ST segment recovery despite early infarct artery patency in patients with Q waves at presentation with a first acute myocardial infarction. Implications of initial Q waves on myocyte reperfusion.
European heart journal 2002;23(18):1449-55.
2002: Marco Roffi; Derek P Chew; Debabrata Mukherjee; Deepak L Bhatt; J A White; David J Moliterno; Christopher Heeschen; C W Hamm; Mark A Robbins; Neal S Kleiman; P Théroux; Harvey D White; Eric J Topol
Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy.
European heart journal 2002;23(18):1441-8.
2002: Craig P Juergens; Harvey D White; Jorge A Belardi; Carlos Macaya; Jordi Soler-Soler; Beat J Meyer; Richard D Levy; Ton Bunt; Joris Menten; Howard C Herrmann; A A Jennifer Adgey; Georgia Tarnesby
A multicenter study of the tolerability of tirofiban versus placebo in patients undergoing planned intracoronary stent placement.
Clinical therapeutics 2002;24(8):1332-44.
2002: John J Edmond; John K French; Hanneke Henny; Lynne M Belz; Teena West; Ralph Stewart; Harvey D White
Prospective evaluation of a chest pain pathway at Green Lane Hospital.
The New Zealand medical journal 2002;115(1158):U103.
2002: Sana M Al-Khatib; Christopher B Granger; Yao Huang; Kerry L Lee; Robert M Califf; Maarten L Simoons; Paul W Armstrong; Frans Van de Werf; Harvey D White; R John Simes; David J Moliterno; Eric J Topol; Robert A Harrington
Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes.
Circulation 2002;106(3):309-12.
2002: R David Anderson; Harvey D White; Erik Ohman; Galen S Wagner; Mitchell W Krucoff; Paul W Armstrong; W Douglas Weaver; W Brian Gibler; Amanda L Stebbins; Robert M Califf; Eric J Topol
Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: a substudy of the GUSTO-III trial. Global Use of Strategies To Open occluded coronary arteries.
American heart journal 2002;144(1):81-8.
2002: Cheuk-Kit Wong; John K French; Wanzhen Gao; Harvey D White
Relation of initial platelet counts to Thrombolysis In Myocardial Infarction-3 flow rates at 90 minutes after commencing fibrinolytic therapy in patients with acute myocardial infarction.
The American journal of cardiology 2002;90(1):54-7.
2002: Harvey D White; Derek P Chew
Bivalirudin: an anticoagulant for acute coronary syndromes and coronary interventions.
Expert opinion on pharmacotherapy 2002;3(6):777-88.
2002: L Kristin Newby; Robert M Califf; Harvey D White; Robert A Harrington; Frans Van de Werf; Christopher B Granger; R John Simes; Vic Hasselblad; Paul W Armstrong
The failure of orally administered glycoprotein IIb/IIIa inhibitors to prevent recurrent cardiac events.
The American journal of medicine 2002;112(8):647-58.
2002: Christopher Heeschen; Christian W Hamm; Ulrich Laufs; Steven M Snapinn; Michael Böhm; Harvey D White
Withdrawal of statins increases event rates in patients with acute coronary syndromes.
Circulation 2002;105(12):1446-52.
2002: Cheuk-Kit Wong; John K French; Jacqueline Andrews; MJ Frey; A A Jennifer Adgey; Philip E G Aylward; Harvey D White
Usefulness of the presenting electrocardiogram in predicting myocardial salvage with thrombolytic therapy in patients with a first acute myocardial infarction.
European heart journal 2002;23(5):399-404.
2002: John K French; Jacqueline Andrews; Samuel O M Manda; Ralph A H Stewart; John J C McTigue; Harvey D White
Early ST-segment recovery, infarct artery blood flow, and long-term outcome after acute myocardial infarction.
American heart journal 2002;143(2):265-71.
2002: Harvey D White
Improved efficacy and less bleeding: further evidence of a unique uncoupling of benefit and risk with bivalirudin.
American heart journal 2002;143(2):189-92.
2002: Stefano Savonitto; Christopher B Granger; Diego Ardissino; Laura Gardner; Claudio Cavallini; Marcello Galvani; Filippo Ottani; Harvey D White; Paul W Armstrong; Erik Ohman; Karen S Pieper; Robert M Califf; Eric J Topol
The prognostic value of creatine kinase elevations extends across the whole spectrum of acute coronary syndromes.
Journal of the American College of Cardiology 2002;39(1):22-9.
2001: Matthew T Roe; Christopher B Granger; JA Puma; Anne S Hellkamp; Judith S Hochman; Erik Ohman; Harvey D White; Frans Van de Werf; Paul W Armstrong; S G Ellis; Robert M Califf; Eric J Topol
Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention.
The American journal of cardiology 2001;88(12):1403-6, A6.
2001: Marco Roffi; Derek P Chew; Debabrata Mukherjee; Deepak L Bhatt; J A White; Christopher Heeschen; C W Hamm; David J Moliterno; Robert M Califf; Harvey D White; Neal S Kleiman; P Théroux; Eric J Topol
Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes.
Circulation 2001;104(23):2767-71.
2001: C Wong; John K French; A Zambanini; Jacqueline Andrews; Philip E G Aylward; A A Jennifer Adgey; MJ Frey; Harvey D White
Relation of pathologic Q waves at presentation and time to streptokinase therapy with early changes in infarct-related artery flow and ventricular wall motion.
The American journal of cardiology 2001;88(5):558-61.
2001: L Kristin Newby; Erik Ohman; Robert H Christenson; D J Moliterno; Robert A Harrington; Harvey D White; Paul W Armstrong; Frans Van de Werf; M Pfisterer; Vic Hasselblad; Robert M Califf; Eric J Topol
Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy.
Circulation 2001;103(24):2891-6.
2001: DJ Amos; John K French; Jacqueline Andrews; Noel G Ashton; Barbara F Williams; R M L Whitlock; Samuel O M Manda; Harvey D White
Corrected TIMI frame counts correlate with stenosis severity and infarct zone wall motion after thrombolytic therapy.
American heart journal 2001;141(4):586-91.
2001: Judith S Hochman; Lynn A Sleeper; Harvey D White; Vladimir Dzavik; S Chiu Wong; Venu Menon; John G Webb; Richard M Steingart; Michael H Picard; Mark Menegus; Jean Boland; Timothy A Sanborn; Christopher E Buller; S Modur; Robert Forman; Patrice Desvigne Nickens; Alice K Jacobs; James N Slater; Thierry H LeJemtel
One-year survival following early revascularization for cardiogenic shock.
JAMA : the journal of the American Medical Association 2001;285(2):190-2.
2000: Harvey D White
Thrombolytic therapy in the elderly.
Lancet 2000;356(9247):2028-30.
2000: Cheuk-Kit Wong; Harvey D White; Robert G Wilcox; Douglas A Criger; Robert M Califf; Eric J Topol; Erik Ohman
New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience.
American heart journal 2000;140(6):878-85.
2000: Eric J Topol; Erik Ohman; Paul W Armstrong; Robert Wilcox; A M Skene; Philip E Aylward; R John Simes; A Dalby; Amadeo Betriu; C Bode; Harvey D White; Judith S Hochman; H Emanuelson; A Vahanian; Shelly K Sapp; Amanda L Stebbins; David J Moliterno; Robert M Califf
Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III Trial.
Circulation 2000;102(15):1761-5.
2000: Neil Van de Water; John K French; Mayanna Lund; TA Hyde; Harvey D White; Peter Browett
Prevalence of factor V Leiden and prothrombin variant G20210A in patients age <50 years with no significant stenoses at angiography three to four weeks after myocardial infarction.
Journal of the American College of Cardiology 2000;36(3):717-22.
2000: Judith S Hochman; Christopher E Buller; Lynn A Sleeper; Jean Boland; Vladimir Dzavik; Timothy A Sanborn; E Godfrey; Harvey D White; J Lim; Thierry H LeJemtel
Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?
Journal of the American College of Cardiology 2000;36(3 Suppl A):1063-70.
2000: Harvey D White; R John Simes; N E Anderson; Graeme J Hankey; J D Watson; D Hunt; David M Colquhoun; Paul Glasziou; S MacMahon; Adrienne C Kirby; Malcolm J West; Andrew M Tonkin
Pravastatin therapy and the risk of stroke.
The New England journal of medicine 2000;343(5):317-26.
2000: K S Woo; L C Armiger; Harvey D White; R M Norris
Can streptokinase produce beneficial effects additional to coronary recanalization? Quantitative microvascular analysis of critically injured reperfused myocardium.
Microvascular research 2000;60(1):8-20.
2000: I T Straznicky; Harvey D White
Thrombolytic therapy for acute myocardial infarction in the elderly.
Coronary artery disease 2000;11(4):299-304.
2000: Jacqueline Andrews; IT Straznicky; John K French; Cynthia L Green; Arthur C P Maas; Mayanna Lund; Mitchell W Krucoff; Harvey D White
ST-Segment recovery adds to the assessment of TIMI 2 and 3 flow in predicting infarct wall motion after thrombolytic therapy.
Circulation 2000;101(18):2138-43.
2000: M Lund; John K French; Harvey D White
Occluded infarct-related arteries and clinical events.
Progress in cardiovascular diseases 2000;42(6):405-18.
2000: John K French; TA Hyde; IT Straznicky; Jacqueline Andrews; Mayanna Lund; DJ Amos; A Zambanini; Christopher J Ellis; Bruce John Webber; SC McLaughlin; R M L Whitlock; Samuel O M Manda; H Patel; Harvey D White
Relationship between corrected TIMI frame counts at three weeks and late survival after myocardial infarction.
Journal of the American College of Cardiology 2000;35(6):1516-24.
2000: Venu Menon; James N Slater; Harvey D White; Lynn A Sleeper; TP Cocke; Judith S Hochman
Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry.
The American journal of medicine 2000;108(5):374-80.
2000: Jacqueline Andrews; John K French; Samuel O M Manda; Harvey D White
New Q waves on the presenting electrocardiogram independently predict increased cardiac mortality following a first ST-elevation myocardial infarction.
European heart journal 2000;21(8):647-53.
2000: L Kristin Newby; E L Eisenstein; Robert M Califf; T D Thompson; C L Nelson; eric peterson; P W Armstrong; Frans Van de Werf; Harvey D White; Eric J Topol; Daniel B Mark
Cost effectiveness of early discharge after uncomplicated acute myocardial infarction.
The New England journal of medicine 2000;342(11):749-55.
2000: M Lund; John K French; R N Johnson; Barbara F Williams; Harvey D White
Serum troponins T and I after elective cardioversion.
European heart journal 2000;21(3):245-53.
1999: Erik Ohman; Paul W Armstrong; Harvey D White; Christopher B Granger; Robert G Wilcox; W Douglas Weaver; W Brian Gibler; Amanda L Stebbins; C Cianciolo; Robert M Califf; Eric J Topol
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries.
The American journal of cardiology 1999;84(11):1281-6.
1999: Harvey D White
Newer antiplatelet agents in acute coronary syndromes.
American heart journal 1999;138(6 Pt 2):S570-6.
1999: David F Kong; Eric J Topol; John A Bittl; Harvey D White; P Théroux; Vic Hasselblad; Robert M Califf
Clinical outcomes of bivalirudin for ischemic heart disease.
Circulation 1999;100(20):2049-53.
1999: J K French; Harvey D White
Antithrombin agents as adjuncts to thrombolytic therapy.
Journal of thrombosis and thrombolysis 1999;8(3):159-66.
1999: John K French; Harvey D White
Direct thrombin inhibitors as adjuncts to thrombolytic therapy.
Current cardiology reports 1999;1(3):184-91.
1999: Kenneth W Mahaffey; Christopher B Granger; Michael A Sloan; Cynthia L Green; Joel M Gore; W Douglas Weaver; Harvey D White; Maarten L Simoons; Gabriel I Barbash; Eric J Topol; Robert M Califf
Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: experience from the GUSTO-I trial. Global Utilization of Streptokinase and tissue-plasminogen activator (tPA) for Occluded Coronary Arteries.
American heart journal 1999;138(3 Pt 1):493-9.
1999: Harvey D White
Future of reperfusion therapy for acute myocardial infarction.
Lancet 1999;354(9180):695-7.
1999: Judith S Hochman; Lynn A Sleeper; John G Webb; Timothy A Sanborn; Harvey D White; JD Talley; Christopher E Buller; Alice K Jacobs; James N Slater; Jacques Col; S M McKinlay; Thierry H LeJemtel
Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.
The New England journal of medicine 1999;341(9):625-34.
1999: TA Hyde; John K French; C K Wong; IT Straznicky; R M L Whitlock; Harvey D White
Four-year survival of patients with acute coronary syndromes without ST-segment elevation and prognostic significance of 0.5-mm ST-segment depression.
The American journal of cardiology 1999;84(4):379-85.
1999: Harvey D White
Optimal treatment of patients with acute coronary syndromes and non-ST-elevation myocardial infarction.
American heart journal 1999;138(2 Pt 2):S105-14.
1999: Judith S Hochman; Jacqueline E Tamis; T D Thompson; W Douglas Weaver; Harvey D White; Frans Van de Werf; Philip E Aylward; Eric J Topol; Robert M Califf
Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators.
The New England journal of medicine 1999;341(4):226-32.
1999: John K French; TA Hyde; H Patel; DJ Amos; SC McLaughlin; Bruce John Webber; Harvey D White
Survival 12 years after randomization to streptokinase: the influence of thrombolysis in myocardial infarction flow at three to four weeks.
Journal of the American College of Cardiology 1999;34(1):62-9.
1999: M E Seddon; John K French; DJ Amos; K Ramanathan; SC McLaughlin; Harvey D White
Waiting times and prioritization for coronary artery bypass surgery in New Zealand.
Heart (British Cardiac Society) 1999;81(6):586-92.
1999: Robyn A North; Lynn Sadler; Alistair W Stewart; Lesley M E McCowan; A R Kerr; Harvey D White
Long-term survival and valve-related complications in young women with cardiac valve replacements.
Circulation 1999;99(20):2669-76.
1999: John H Alexander; Christopher B Granger; Zygmunt Sadowski; Philip E Aylward; Harvey D White; TD Thompson; Robert M Califf; Eric J Topol
Prophylactic lidocaine use in acute myocardial infarction: incidence and outcomes from two international trials. The GUSTO-I and GUSTO-IIb Investigators.
American heart journal 1999;137(5):799-805.
1999: David Hasdai; Amir Lerman; Charanjit S Rihal; Douglas A Criger; Kirk N Garratt; A Betriu; Harvey D White; Eric J Topol; Christopher B Granger; Stephen G Ellis; Robert M Califf; David R Holmes
Smoking status and outcome after primary coronary angioplasty for acute myocardial infarction.
American heart journal 1999;137(4 Pt 1):612-20.
1999: JA Puma; Michael H Sketch; TD Thompson; R J Simes; D C Morris; Harvey D White; Eric J Topol; Robert M Califf
Support for the open-artery hypothesis in survivors of acute myocardial infarction: analysis of 11,228 patients treated with thrombolytic therapy.
The American journal of cardiology 1999;83(4):482-7.
1999: Harvey D White
Is thrombin a pharmacological target during reperfusion?
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1999;10 Suppl 1():S55-7.
1999: David R Holmes; Harvey D White; K S Pieper; Stephen G Ellis; Robert M Califf; Eric J Topol
Effect of age on outcome with primary angioplasty versus thrombolysis.
Journal of the American College of Cardiology 1999;33(2):412-9.
1999: John K French; IT Straznicky; Bruce John Webber; Philip E G Aylward; MJ Frey; A A Jennifer Adgey; Barbara F Williams; SC McLaughlin; Harvey D White
Angiographic frame counts 90 minutes after streptokinase predict left ventricular function at 48 hours following myocardial infarction.
Heart (British Cardiac Society) 1999;81(2):128-33.
1999: Cheuk-Kit Wong; John K French; Philip E G Aylward; MJ Frey; A A Jennifer Adgey; Harvey D White
Usefulness of the presenting electrocardiogram in predicting successful reperfusion with streptokinase in acute myocardial infarction.
The American journal of cardiology 1999;83(2):164-8.
1999: John K French; DJ Amos; Barbara F Williams; D B Cross; J M Elliott; H H Hart; M G Williams; R M Norris; Noel G Ashton; R M L Whitlock; SC McLaughlin; Harvey D White
Effects of early captopril administration after thrombolysis on regional wall motion in relation to infarct artery blood flow.
Journal of the American College of Cardiology 1999;33(1):139-45.
1998: David F Kong; Robert M Califf; D P Miller; David J Moliterno; Harvey D White; Robert A Harrington; James E Tcheng; A Michael Lincoff; Vic Hasselblad; Eric J Topol
Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease.
Circulation 1998;98(25):2829-35.
1998: Christopher J Ellis; A Zambanini; John K French; M Denton; R Johnson; H Patel; Harvey D White
Inadequate control of lipid levels in patients with a previous myocardial infarction.
The New Zealand medical journal 1998;111(1079):464-7.
1998: Harvey D White
Direct thrombin inhibition and thrombolytic therapy: rationale for the Hirulog and Early Reperfusion/Occlusion (HERO-2) trial.
The American journal of cardiology 1998;82(8B):57P-62P.
1998: Michael A Sloan; Cathy A Sila; Kenneth W Mahaffey; Christopher B Granger; W T Longstreth; Peter J Koudstaal; Harvey D White; Joel M Gore; Maarten L Simoons; W Douglas Weaver; Cynthia L Green; Eric J Topol; Robert M Califf
Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage.
Circulation 1998;98(14):1376-82.
1998: John K French; Christopher J Ellis; Harvey D White
The corrected TIMI frame count. The new gold standard?
Australian and New Zealand journal of medicine 1998;28(4):569-73.
1998: Harvey D White; John K French; Christopher J Ellis
New antiplatelet agents.
Australian and New Zealand journal of medicine 1998;28(4):558-64.
1998: Harvey D White; Christopher J Ellis; John K French
Low molecular weight heparins in acute ischaemic syndromes.
Australian and New Zealand journal of medicine 1998;28(4):555-7.
1998: Harvey D White; Christopher J Ellis; John K French; P Aylward
Hirudin (desirudin) and Hirulog (bivalirudin) in acute ischaemic syndromes and the rationale for the Hirulog/Early Reperfusion Occlusion (HERO-2) Study.
Australian and New Zealand journal of medicine 1998;28(4):551-4.
1998: Christopher J Ellis; John K French; Harvey D White
Thrombolytic eligibility.
Australian and New Zealand journal of medicine 1998;28(4):518-24.
1998: Harvey D White; E Braunwald
Applying the open artery theory: use of predictive survival markers.
European heart journal 1998;19(8):1132-9.
1998: Christopher J Ellis; John K French; Harvey D White; John A Ormiston; R M L Whitlock; Mark W I Webster
Results of percutaneous coronary angioplasty in patients <40 years of age.
The American journal of cardiology 1998;82(2):135-9.
1998: J T Stewart; John K French; Pierre Théroux; K Ramanathan; B Charles Solymoss; R Johnson; Harvey D White
Early noninvasive identification of failed reperfusion after intravenous thrombolytic therapy in acute myocardial infarction.
Journal of the American College of Cardiology 1998;31(7):1499-505.
1998: B K Metz; Harvey D White; Christopher B Granger; R J Simes; Paul W Armstrong; J Hirsh; V Fuster; C M MacAulay; Robert M Califf; Eric J Topol
Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators.
Journal of the American College of Cardiology 1998;31(7):1493-8.
1998: IT Straznicky; A Zambanini; Harvey D White
Ongoing clinical trials of anti-platelet agents in the management of acute ischaemic coronary syndromes.
Expert opinion on investigational drugs 1998;7(5):811-21.
1998: A Zambanini; John K French; M W Webster; Harvey D White
The roles for coronary surgery and angioplasty in the management of patients with stable angina: evidence and decision making.
Journal of evaluation in clinical practice 1998;4(2):93-102.
1998: Harvey D White; F J Van de Werf
Thrombolysis for acute myocardial infarction.
Circulation 1998;97(16):1632-46.
1998: John K French; Christopher J Ellis; Bruce John Webber; Barbara F Williams; DJ Amos; K Ramanathan; R M L Whitlock; Harvey D White
Abnormal coronary flow in infarct arteries 1 year after myocardial infarction is predicted at 4 weeks by corrected Thrombolysis in Myocardial Infarction (TIMI) frame count and stenosis severity.
The American journal of cardiology 1998;81(6):665-71.
1998: Kenneth W Mahaffey; Christopher B Granger; Michael A Sloan; TD Thompson; Joel M Gore; W Douglas Weaver; Harvey D White; Maarten L Simoons; Gabriel I Barbash; Eric J Topol; Robert M Califf
Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-I.
Circulation 1998;97(8):757-64.
1998: James Gebel; Cathy A Sila; Michael A Sloan; Christopher B Granger; Kenneth W Mahaffey; J Weisenberger; Cynthia L Green; Harvey D White; Joel M Gore; W Douglas Weaver; Robert M Califf; Eric J Topol
Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Stroke; a journal of cerebral circulation 1998;29(3):563-9.
1998: D B Brieger; Koon-Hou Mak; Harvey D White; Neal S Kleiman; DP Miller; Alec Vahanian; A M Ross; Robert M Califf; Eric J Topol
Benefit of early sustained reperfusion in patients with prior myocardial infarction (the GUSTO-I trial). Global Utilization of Streptokinase and TPA for occluded arteries.
The American journal of cardiology 1998;81(3):282-7.
1997: Kenneth W Mahaffey; Christopher B Granger; C A Toth; Harvey D White; Amanda L Stebbins; Gabriel I Barbash; A Vahanian; Eric J Topol; Robert M Califf
Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1997;30(7):1606-10.
1997: Harvey D White; Philip E G Aylward; MJ Frey; A A Jennifer Adgey; R Nair; W S Hillis; Y Shalev; M A Brown; John K French; R Collins; J Maraganore; B Adelman
Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators.
Circulation 1997;96(7):2155-61.
1997: Harvey D White
Unmet therapeutic needs in the management of acute ischemia.
The American journal of cardiology 1997;80(4A):2B-10B.
1997: Barbara F Williams; John K French; Harvey D White
Is our method of obtaining consent appropriate for randomised controlled trials in acute myocardial infarction?
The New Zealand medical journal 1997;110(1049):298-9.
1997: R Q Migrino; James B Young; Stephen G Ellis; Harvey D White; Conor F Lundergan; D P Miller; Christopher B Granger; Allan M Ross; Robert M Califf; Eric J Topol
End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic Investigators.
Circulation 1997;96(1):116-21.
1997: Koon-Hou Mak; David J Moliterno; Christopher B Granger; DP Miller; Harvey D White; Robert G Wilcox; Robert M Califf; Eric J Topol
Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1997;30(1):171-9.
1997: Harvey D White
Clinical trials of direct thrombin inhibitors in acute ischaemic syndromes.
Thrombosis and haemostasis 1997;78(1):364-6.
1997: E K Moen; C R Asher; DP Miller; W D Weaver; Harvey D White; Robert M Califf; Eric J Topol
Long-term follow-up of gender-specific outcomes after thrombolytic therapy for acute myocardial infarction from the GUSTO-I trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Journal of women's health / the official publication of the Society for the Advancement of Women's Health Research 1997;6(3):285-93.
1997: David R Holmes; Robert M Califf; F Van de Werf; Peter B Berger; Eric R Bates; Maarten L Simoons; Harvey D White; TD Thompson; Eric J Topol
Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial.
Lancet 1997;349(9045):75-8.
1997: S L Woodfield; Conor F Lundergan; Jonathan S Reiner; M A Thompson; SC Rohrbeck; Y Deychak; J O Smith; J R Burton; WF McCarthy; Robert M Califf; Harvey D White; W D Weaver; Eric J Topol; Allan M Ross
Gender and acute myocardial infarction: is there a different response to thrombolysis?
Journal of the American College of Cardiology 1997;29(1):35-42.
1996: Philip E Aylward; Robert G Wilcox; J H Horgan; Harvey D White; Christopher B Granger; Robert M Califf; Eric J Topol
Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I Investigators.
Annals of internal medicine 1996;125(11):891-900.
1996: Harvey D White; Gabriel I Barbash; Robert M Califf; R J Simes; Christopher B Granger; W D Weaver; N S Kleiman; Philip E Aylward; Joel M Gore; A Vahanian; Kerry L Lee; A M Ross; Eric J Topol
Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial.
Circulation 1996;94(8):1826-33.
1996: Robert M Califf; Harvey D White; Frans Van de Werf; Zygmunt Sadowski; P W Armstrong; A Vahanian; Maarten L Simoons; R J Simes; Kerry L Lee; Eric J Topol
One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. GUSTO-I Investigators.
Circulation 1996;94(6):1233-8.
1996: John K French; Mark W I Webster; JM Neutze; Harvey D White
Evidence-based assessment of the benefit of revascularisation in coronary disease: beyond the randomised trials.
Australian and New Zealand journal of medicine 1996;26(4):490-4.
1996: R M Norris; Harvey D White; H H Hart; Barbara F Williams
Comparison of aspirin with a thromboxane antagonist for patients with prolonged chest pain and ST segment depression.
The New Zealand medical journal 1996;109(1026):278-80.
1996: John K French; Barbara F Williams; H H Hart; S Wyatt; J E Poole; C Ingram; Christopher J Ellis; M G Williams; Harvey D White
Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction.
BMJ (Clinical research ed.) 1996;312(7047):1637-41.
1996: R M Norris; R N Johnson; Harvey D White; D R Robinson
Non-invasive diagnosis of infarct artery patency after acute myocardial infarction by use of serial plasma troponin T concentrations: importance of measurement of peak levels.
Heart (British Cardiac Society) 1996;75(5):481-5.
1996: W D Weaver; Harvey D White; Robert G Wilcox; Philip E Aylward; D Morris; AD Guerci; Erik Ohman; Gabriel I Barbash; A Betriu; Zygmunt Sadowski; Eric J Topol; Robert M Califf
Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
JAMA : the journal of the American Medical Association 1996;275(10):777-82.
1996: Christopher B Granger; J Hirsch; Robert M Califf; J Col; Harvey D White; A Betriu; L H Woodlief; Kerry L Lee; E G Bovill; R J Simes; Eric J Topol
Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial.
Circulation 1996;93(5):870-8.
1996: H Patel; JM Neutze; B Kerr; Harvey D White
Failure of implementation of the National Heart Foundation of New Zealand guidelines for the management of dyslipidaemia.
The New Zealand medical journal 1996;109(1015):24-6.
1995: S L Karnash; Christopher B Granger; Harvey D White; L H Woodlief; Eric J Topol; Robert M Califf
Treating menstruating women with thrombolytic therapy: insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-I) trial.
Journal of the American College of Cardiology 1995;26(7):1651-6.
1995: Joel M Gore; Christopher B Granger; Maarten L Simoons; Michael A Sloan; W D Weaver; Harvey D White; Gabriel I Barbash; Frans Van de Werf; Philip E Aylward; Eric J Topol
Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries.
Circulation 1995;92(10):2811-8.
1995: Harvey D White
Angioplasty versus bypass surgery.
Lancet 1995;346(8984):1174-5.
1995: Gabriel I Barbash; J Reiner; Harvey D White; Robert G Wilcox; P W Armstrong; Z Sadowski; D Morris; Philip E Aylward; L H Woodlief; Eric J Topol
Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1995;26(5):1222-9.
1995: JM Neutze; Harvey D White
A direct threat to research in public hospitals.
The New Zealand medical journal 1995;108(1005):320-2.
1995: Harvey D White; John K French; R M Norris; Barbara F Williams; H H Hart; D B Cross
Effects of streptokinase in patients presenting within 6 hours of prolonged chest pain with ST segment depression.
British heart journal 1995;73(6):500-5.
1995: G I Barbash; Harvey D White; M Modan; R Diaz; J R Hampton; J Heikkila; A Kristinsson; S Moulopoulos; Ernesto Andres Cesar Paolasso; T Van der Werf
Acute myocardial infarction in the young--the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
European heart journal 1995;16(3):313-6.
1995: Harvey D White; D B Cross; Barbara F Williams; R M Norris; K S Woo; A W Hamer; J M Elliott; John A Ormiston
"Rescue" thrombolysis with intracoronary tissue plasminogen activator for failed intravenous thrombolysis with streptokinase for acute myocardial infarction.
The American journal of cardiology 1995;75(2):172-4.
1995: Harvey D White; John K French; A W Hamer; M A Brown; Barbara F Williams; John A Ormiston; D B Cross
Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: effects of antiplatelet therapy.
Journal of the American College of Cardiology 1995;25(1):218-23.
1995: Harvey D White
Effects of thrombolytic therapy on left ventricular function and the importance of long-term patency of the infarct-related artery.
Clinical science (London, England : 1979) 1995;88(1):21-4.
1994: Christopher B Granger; Harvey D White; Eric R Bates; Erik Ohman; Robert M Califf
A pooled analysis of coronary arterial patency and left ventricular function after intravenous thrombolysis for acute myocardial infarction.
The American journal of cardiology 1994;74(12):1220-8.
1994: A W Hamer; M Takayama; K A Abraham; A H Roche; Alan R Kerr; Barbara F Williams; M C Ramage; Harvey D White
End-systolic volume and long-term survival after coronary artery bypass graft surgery in patients with impaired left ventricular function.
Circulation 1994;90(6):2899-904.
1994: Neal S Kleiman; Harvey D White; Erik Ohman; A M Ross; L H Woodlief; Robert M Califf; D R Holmes; Eric R Bates; M Pfisterer; A Vahanian
Mortality within 24 hours of thrombolysis for myocardial infarction. The importance of early reperfusion. The GUSTO Investigators, Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Circulation 1994;90(6):2658-65.
1994: G I Barbash; Harvey D White; M Modan; R Diaz; J R Hampton; J Heikkila; A Kristinsson; S Moulopoulos; Ernesto Andres Cesar Paolasso; T Van der Werf
Outcome of thrombolytic therapy in relation to hospital size and invasive cardiac services. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
Archives of internal medicine 1994;154(19):2237-42.
1994: Harvey D White
Aspirin or warfarin for non-rheumatic atrial fibrillation?
Lancet 1994;343(8899):683-4.
1994: Harvey D White; D B Cross; J M Elliott; R M Norris; T W Yee
Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction.
Circulation 1994;89(1):61-7.
1993: Harvey D White; G I Barbash; M Modan; R John Simes; R Diaz; J R Hampton; J Heikkilä; A Kristinsson; S Moulopoulos; Ernesto Andres Cesar Paolasso
After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Study.
Circulation 1993;88(5 Pt 1):2097-103.
1993: R M Norris; Harvey D White; D B Cross; K S Woo; A H Maslowski; M P Caruana; H H Hart; B Williams
Aspirin does not improve early arterial patency after streptokinase treatment for acute myocardial infarction.
British heart journal 1993;69(6):492-5.
1993: R M Norris; Harvey D White; D B Cross; K S Woo; J M Elliott; D Twigden; B Williams; R N Johnson
Non-invasive diagnosis of arterial patency after thrombolytic treatment and its relation to prognosis.
British heart journal 1993;69(6):485-91.
1993: A W Hamer; Harvey D White
Women and coronary heart disease.
The New Zealand medical journal 1993;106(955):176-7.
1993: J M Elliott; D B Cross; S A Cederholm-Williams; Harvey D White
Neutralizing antibodies to streptokinase four years after intravenous thrombolytic therapy.
The American journal of cardiology 1993;71(8):640-5.
1993: John K French; J M Elliott; Barbara F Williams; D J Nixon; M A Denton; Harvey D White
Association of angiographically detected coronary artery disease with low levels of high-density lipoprotein cholesterol and systemic hypertension.
The American journal of cardiology 1993;71(7):505-10.
1993: R M Norris; D G Twigden; Barbara F Williams; R N Johnson; Harvey D White
Use of creatine kinase isoforms for diagnosis of infarct artery patency after thrombolytic therapy with streptokinase.
Coronary artery disease 1993;4(2):201-5.
1993: G I Barbash; Harvey D White; M Modan; R Diaz; J R Hampton; J Heikkila; A Kristinsson; S Moulopoulos; Ernesto Andres Cesar Paolasso; T Van der Werf
Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
Circulation 1993;87(1):53-8.
1992: R M Norris; Harvey D White; D B Cross; C J Wild; R M L Whitlock
Prognosis after recovery from myocardial infarction: the relative importance of cardiac dilatation and coronary stenoses.
European heart journal 1992;13(12):1611-8.
1992: Harvey D White
Heart failure: to digitalise or not? The view against.
Australian and New Zealand journal of medicine 1992;22(5 Suppl):626-30.
1992: Harvey D White
Remodelling of the heart after myocardial infarction.
Australian and New Zealand journal of medicine 1992;22(5 Suppl):601-6.
1992: Harvey D White
Thrombolytic therapy for patients with myocardial infarction presenting after six hours.
Lancet 1992;340(8813):221-2.
1992: R M Norris; P A Ockelford; D B Cross; J T Rivers; J M Smith; M Takayama; Harvey D White
Reduced synthesis of tissue plasminogen activator by vascular endothelium during acute myocardial infarction.
Australian and New Zealand journal of medicine 1992;22(3):261-4.
1992: J M Elliott; Barbara F Williams; Harvey D White
Streptokinase and lifestyle outcome in survivors of myocardial infarction.
The New Zealand medical journal 1992;105(933):163-4.
1991: J M Elliott; Harvey D White
Regression of atherosclerosis: fact or fiction?
The New Zealand medical journal 1991;104(925):510-2.
1991: Harvey D White
Comparative safety of thrombolytic agents.
The American journal of cardiology 1991;68(16):30E-37E.
1991: Harvey D White
Thrombolytic therapy. Introduction.
The American journal of cardiology 1991;68(16):1E-2E.
1991: D B Cross; N G Ashton; R M Norris; Harvey D White
Comparison of the effects of streptokinase and tissue plasminogen activator on regional wall motion after first myocardial infarction: analysis by the centerline method with correction for area at risk.
Journal of the American College of Cardiology 1991;17(5):1039-46.
1990: Harvey D White; D B Cross; Barbara F Williams; R M Norris
Safety and efficacy of repeat thrombolytic treatment after acute myocardial infarction.
British heart journal 1990;64(3):177-81.
1990: Harvey D White
GISSI-2 and the heparin controversy.
Lancet 1990;336(8710):297-8.
1990: J T Rivers; Harvey D White; D B Cross; Barbara F Williams; R M Norris
Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management: incidence and effect of smoking.
Journal of the American College of Cardiology 1990;16(2):340-8.
1990: Harvey D White
Relation of thrombolysis during acute myocardial infarction to left ventricular function and mortality.
The American journal of cardiology 1990;66(1):92-5.
1990: Harvey D White; D B Cross; R M Norris
Thrombolytic therapy and recurrent myocardial infarction.
The New Zealand medical journal 1990;103(887):163-4.
1990: John K French; Harvey D White; S C Greaves
Simvastatin therapy for hypercholesterolaemia in patients with coronary heart disease.
The New Zealand medical journal 1990;103(883):41-3.
1989: Harvey D White
Acute myocardial infarction: a true medical emergency.
The New Zealand medical journal 1989;102(869):281-3.
1989: Harvey D White
Comparison of tissue plasminogen activator and streptokinase in the management of acute myocardial infarction.
Chest 1989;95(5 Suppl):265S-269S.
1989: Harvey D White; J T Rivers; A H Maslowski; John A Ormiston; M Takayama; H H Hart; D N Sharpe; R M L Whitlock; R M Norris
Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction.
The New England journal of medicine 1989;320(13):817-21.
1988: M Takayama; R M Norris; M A Brown; L C Armiger; J T Rivers; Harvey D White
Postsystolic shortening of acutely ischemic canine myocardium predicts early and late recovery of function after coronary artery reperfusion.
Circulation 1988;78(4):994-1007.
1988: R M Norris; Harvey D White
Therapeutic trials in coronary thrombosis should measure left ventricular function as primary end-point of treatment.
Lancet 1988;1(8577):104-6.
1987: Harvey D White; R M Norris; M A Brown; M Takayama; A Maslowski; N M Bass; John A Ormiston; T Whitlock
Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction.
The New England journal of medicine 1987;317(14):850-5.
1987: Harvey D White; R M Norris; M A Brown; P W Brandt; R M L Whitlock; C J Wild
Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.
Circulation 1987;76(1):44-51.